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Abstract
Intracellular Ca2+ signals carry out crucial roles in neurons. In order to interpret 
these Ca2+ signals into different changes in neuronal function, a number of Ca2+ 
sensor proteins are required to respond selectively to defined signals and 
modulate neuronal activity appropriately. These Ca2+ sensing proteins include 
the neuronal calcium sensor (NCS) proteins. The NCS proteins contain EF-hand 
Ca2+ binding domains and provide selectivity by their differing Ca2+ affinities, 
localisation, kinetics and expression patterns. This thesis focuses on one 
particular sub-family of the NCS proteins, the K+ channel interacting proteins 
(KChIPs). Previous studies have demonstrated the ability of the KChIPs to 
regulate the function and traffic of Kv4 potassium channels, which play 
important roles in the control of neuronal excitability. However, one of the 
KChIPs, KChIP3, has been demonstrated to have two other well-characterised 
functions and as a consequence has been given two other names. Firstly it was 
shown to interact with the presenilins and was subsequently named calsenilin. 
Furthermore, it was demonstrated to play a role in the regulation of transcription 
through binding to the DRE DNA motif, hence it has also been named DREAM.
Here I have explored the extent to which the KChIPs share similar functional 
properties by carrying out a comparative study of selected isoforms of KChIPs 1- 
4 and some of their known functions, utilising GFP-variant fusion proteins 
expressed in COS-7 and PC 12 cells. Co-expression of all four KChIPs with the 
Kv4.2 channel resulted in increased traffic of the channel to the plasma 
membrane, indicating that all four KChIPs share this particular functional 
property. By contrast, only KChIP2 was demonstrated to have an effect upon 
the traffic of the Kvl .4 channel to the plasma membrane, with traffic of the 
channel inhibited by co-expression with KChIP2. Similarly, only KChIP3 co­
localised with presenilin-1, indicating that whilst the KChIPs do possess the 
ability to perform multiple functions in common with each other, they also 
maintain distinct individual properties.
Another NCS protein, NCS-1, has also been reported to be able to carry out 
some of the functional roles of the KChIPs, such as the stimulation of traffic of 
Kv4 channels. Whilst unable to confirm these interactions in this study, I have 
investigated the potential for the KChIPs to share one of the functional properties 
of NCS-1, a role in the stimulation of exocytosis by utilising a well established 
assay. Of the KChIPs examined, KChIP3 specifically was found to significantly 
increase secretion from PC 12 cells in response to purinergic receptor 
stimulation. This increase in secretion appeared to be as a result of a 
modification of the Ca2+ signal seen in response to ATP stimulation, with 
KCMP3 expression resulting in a prolonged increase in [Ca2+]j. These data 
provide evidence for a novel and specific role of KChIP3 and suggest that the 
KChIPs may have distinct roles in regulation of neuronal function.
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CHAPTER 1:
Introduction
1.1 Ca2+ signalling in neurons
Ca2+ is an important intracellular messenger, with intracellular Ca2+ signals carrying 
out crucial roles in neurons, such as controlling neurotransmitter release, regulating 
gene transcription and cell death, modulating channel function and inducing changes 
in synaptic plasticity (Berridge et al., 2000; Carafoli, 2002). Neurons generally 
maintain a resting intracellular concentration of Ca2+ within the range of 40-100nM 
(Maravall et al., 2000; Sabatini et al., 2002), but the receipt of a neurotransmitter 
signal from another neuron, or some other form of stimulation, can lead to a change 
in intracellular Ca2+ concentration that can vary both temporally and spatially. These 
changes can range from being highly localised and transient Ca elevations to 
longer lasting and global changes throughout the neuron (Augustine et al., 2003). 
The changes in intracellular Ca2+ concentration can be facilitated by a number of 
extracellular and intracellular sources of Ca2+. For example, Ca2+ can enter the cell 
through plasma membrane channels such as voltage-gated Ca2+ channels or NMDA 
(N-methyl-D-aspartate) receptors, or be released from intracellular stores such as the 
ER in response to messengers such as inositol 1,4,5-trisphosphate (Berridge, 1998).
As the Ca2+ concentration is over 1000 fold higher in the extracellular space than in 
the cytosol, the opening of Ca2+ channels in the plasma membrane results in an 
influx of calcium. Voltage gated channels open during membrane depolarisation 
and are involved in the generation of Ca2+ signals in presynaptic terminals that 
modulate the exocytotic machinery and trigger the rapid release of neurotransmitters
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(Sabatini & Regehr, 1996; Stanley, 1997; Turner et al., 1999; Yoshihara et al.,
2003). Receptor operated channels are controlled by neurotransmitters and are 
predominantly located at postsynaptic sites. NMDA receptors for example are
2+activated by the binding of their ligand, glutamate, and they open and allow Ca to 
flow into the cell.
Other cell surface receptors are not ionotrophic as NMDA receptors are, and as such 
are not permeable to Ca2+ ions. Instead, these metabotrophic receptors act to 
stimulate polyphosphoinositide metabolism resulting in the release of Ca2+ from 
intracellular stores (Frenguelli et al., 1993). Phosphatidylinositol 4,5-bisphosphate 
(PtDIns[4,5]P2) is hydrolysed to form the second messengers diacylglcerol (DAG) 
and inositol 1,4,5-trisphosphate (InsPs), and it is InsP3 that triggers Ca2+ release from 
intracellular stores such as the ER (Streb et al., 1983; Pin & Duvoisin, 1995).
The ER is perhaps the most important intracellular Ca2+ store. In neurons it extends 
as a continuous network throughout the whole cell, including the dendrites and 
dendritic spine (Broadwell & Cataldo, 1983,1984; Spacek & Harris, 1997). The 
Golgi can also act as an intracellular Ca2+ store (Pinton et al., 1998), whilst 
mitochondria can also take up large amounts of Ca2+ and thus are also involved in 
regulating cytosolic Ca2+ levels (Rizzuto, 2001), but the ER would appear to be the 
main Ca2+ store. It can release Ca2+ through the activation of InsP3 receptors or 
ryanodine receptors either by their individual ligands (InsP3 and cyclic ADP ribose 
respectively) (Henzi & MacDermott, 1992) or by Ca2+ itself through a process
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known as calcium induced calcium release, where Ca signals can be amplified, 
propagating Ca2+ waves that can in turn develop into global events (Verkhratsky & 
Shmigol, 1996). Ca2+ signals can also be highly localised, where only small groups 
of InsP3 or ryanodine receptors open (‘elementary events’) (Bootman & Berridge, 
1995; Bootman et al., 1995). In addition, the morphological characteristics of 
neurons can also affect Ca2+ signals. Ca2+ concentration can be increased in 
dendritic spines without changes in the adjacent dendrite due to the limited diffusion 
of Ca2+ through the narrow necks of the spines -  the head of the dendritic spine 
(volume -0.01-1 pm3) is connected to the parent dendrite by a thin neck (diameter 
-0.1 pm) which leads to a geometric constriction and thus prevents diffusion of the 
Ca2+ signal (Sabatini et al., 2001; Sabatini et al., 2002).
Termination of Ca2+ signals and the return of the intracellular Ca2+ concentration to 
its resting level can occur via a variety of mechanisms. Ca can be sequestered back 
into the ER by the sarco(endo)plasmic reticulum Ca -ATPase (SERCA) pumps 
(Lipscombe et al., 1988) or it can be pumped out of the cell. In the latter case, Ca2+ 
can be extruded from the cell either by plasma membrane Ca -ATPase (PMCA) 
activity or via the Na+/Ca2+ exchanger, where three Na+ ions are exchanged for the 
removal of one Ca2+ ion from the cell (Fierro et al., 1998). The SERCA and PMCA 
pumps utilise the energy provided by ATP hydrolysis to transport Ca2+ against its 
concentration gradient from the cytosol to the ER lumen or indeed out of the cell. 
Both of these pumps have high Ca2+ affinities and play a vital role in maintaining 
resting Ca2+ concentrations within the cytosol (Berridge et al., 2003).
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The distinct types of Ca signal that occur, differing temporally, spatially and in 
magnitude, contribute partially to the diversity of neuronal functions controlled by 
Ca2+ (Berridge et al., 2000). However, in order for these different signals to be 
interpreted into different changes in neuronal function, a number of Ca sensor 
proteins are required that are able to respond selectively to defined signals and 
modulate cellular activity appropriately. The effects of these Ca sensing proteins
' y  i
can depend upon a variety of factors, such as their localisation in relation to the Ca
fS I
signal, the affinity of the protein for Ca and their interaction with other proteins 
(Ikura & Ames, 2006).
< y t
One of the most widely studied Ca sensing proteins is the ubiquitously expressed 
protein calmodulin (Chin & Means, 2000) and a variety of its cellular functions, 
such as its role in synaptic plasticity, have been defined in detail (Lisman et al., 
2002). Another Ca sensing protein, synaptotagmin, is now well established as the 
Ca sensor for fast neurotransmission (Femandez-Chacon et al., 2001). A number 
of other Ca2+-binding proteins related to calmodulin are enriched or expressed solely 
in the nervous system where they carry out distinct roles in the regulation of 
neuronal function. These include the neuronal calcium sensor (NCS) protein family, 
which provide selectivity by their differing Ca affinities, localisation, kinetics and 
expression patterns (Burgoyne & Weiss, 2001; O'Callaghan & Burgoyne, 2003) and 
have been implicated in a wide range of Ca signalling events in neurons and 
photoreceptors (Burgoyne & Weiss, 2001; Burgoyne et al., 2004). A basic model of 
calcium signalling is shown in figure 1.
5
Figure 1. Basic model of intracellular calcium signals.
Influx of external Ca2+ is mediated by voltage-operated (VOC) or receptor operated 
channels (ROC) controlled by ionotropic neurotransmitters. Metabotrophic 
receptors can also be activated to stimulate polyphosphoinositide metabolism 
resulting in the release of calcium from intracellular stores through the activation 
of InsP3 or ryanodine receptors by the appropriate second messengers. The Ca2+ 
signal can be terminated by a number of mechanisms that include removing Ca2+ 
from the cell by the plasma-membrane Ca2+-ATPase (PMCA) or the Na+/Ca2+ 
exchanger, or sequestering Ca2+ back into the ER by the action of the 
sarco(endo)plasmic reticulum Ca2+-ATPase (SERCA).
(derived and modified from the Proceedings of the 9th meeting of the European 
Calcium Society, 2006).
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1.2 The Neuronal Calcium Sensor (NCS) proteins
1.2.1 General Overview
The NCS proteins have been identified in multiple organisms ranging from yeast to 
man, with the NCS protein family being encoded by 14 genes in the human genome. 
It is likely that the 14 members of the family are conserved throughout all 
mammalian species, and in some cases this diversity is increased by the existence of 
splice variants. They are small EF-hand containing proteins (generally 22-25kDa) 
that can bind Ca2+ with micromolar or submicromolar affinities (0.1-1 pM), meaning 
that they can bind Ca2+ at levels not far above resting intracellular levels. Upon Ca2+ 
binding, the NCS proteins undergo conformational changes enabling their 
interaction with and subsequent regulation of other proteins, leading to changes in 
physiological function. They are primarily expressed in neurons and neuroendocrine 
cells but have also been shown to be expressed in tissues other than the brain, 
including the heart and testes (Braunewell & Gundelfinger, 1999; An et al., 2000; 
Burgoyne & Weiss, 2001).
The NCS proteins include NCS-1 (neuronal calcium sensor-1), recoverin, the 
VILIPS/neurocalcins (visinin-like proteins), GCAPs (guanylyl cyclase-activating 
proteins) and KChIPs (potassium channel interacting proteins) (Braunewell et al., 
1997; Braunewell & Gundelfinger, 1999; Burgoyne & Weiss, 2001) and have a vast 
array of functions that include effects on neurotransmitter release (McFerran et al.,
7
1998), learning and memory (Gomez et al., 2001), receptor and channel trafficking 
(Kabbani et al., 2002; O'Callaghan et al., 2003a), and regulation of channel function 
(An et al., 2000; Burgoyne & Weiss, 2001) to name but a few. During evolution the 
NCS family has become progressively more complex, such that there are now five 
classes of NCS proteins (A-E) that have been defined based upon their amino acid 
sequences. This information is summarised in figure 2. Three NCS proteins are 
expressed in C.elegans whilst D.melanogaster has four NCS proteins. Zebrafish 
have two NCS-1 orthologues (Blasiole et al., 2005), up to eight class B proteins, a 
recoverin, at least eight GCAPs (Palczewski et al., 2004) and five KChIPs. 
Mammals meanwhile have a highly conserved set of 14 NCS genes. These encode a 
single NCS-1, five class B proteins, one recoverin, three GCAPs and four KChIPs, 
with sixteen alternatively spliced variants of the KChIPs currently identified 
(Pruunsild & Timmusk, 2005). In all species, the GCAPs and recoverin are 
expressed in the retina whilst the remaining NCS proteins are expressed to varying 
degrees in neurons, sometimes with very specific expression patterns in particular 
sub-populations of neurons (Kobayashi et al., 1993; Paterlini et al., 2000; Pruunsild 
& Timmusk, 2005).
Structurally, all of the NCS proteins contain four Ca2+-binding EF-hand domains in 
common with calmodulin, although the similarity to calmodulin is limited (no more 
than 20% identity) (Burgoyne, 2007). Each EF-hand domain consists of a helix- 
loop-helix structure, first characterised for the protein parvalbumin, where helices E 
and F are positioned like the forefinger and thumb of the right hand and form the
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Ca2+ binding motif, hence the name EF-hand (Kretsinger & Nockolds, 1973). The 
helix-loop-helix structure consists of 29 amino acids and binds a single calcium ion. 
There are six residues involved in Ca2+binding at positions 1, 3, 5, 7, 9, and 12 
within the EF-hand, with position 1 being a highly conserved aspartate and position 
12 either aspartate or glutamate. The first EF-hand (nearest the N-terminal) in all 
NCS proteins is unable to bind Ca2+ due to the presence of a conserved cysteine- 
proline substitution in the binding loop (Hwang et al., 2004), whilst EF-hand 4, in 
some NCS proteins such as recoverin, is also unable to bind Ca2+ due to an internal 
lysine-glutamate salt bridge (Ames et al., 1997). Thus either two or three Ca2+ ions 
will bind to the NCS proteins and induce the appropriate conformational changes 
relative to their function (figure 3). EF-hand-containing proteins can have fast on- 
rates, with Ca2+ binding limited only by the rate of Ca2+ diffusion. However, the 
equilibrium dissociation constant can be variable due to differences in the Ca off- 
rate between different EF-hands -  this depends upon the nature of the amino acid at 
position 9 of the EF hand (Falke et al., 1994). The slowest off-rates are found in 
proteins that act as Ca buffers.
Another common feature of most of the NCS proteins (with the exception of KChEPs 
2-4) is the N-terminal myristoyl tail (figure 3) (Burgoyne & Weiss, 2001). N- 
terminal myristoylation is the post-translational attachment of myristate, a 14-carbon 
saturated fatty acid, to the N-terminal glycine of the protein upon removal of the 
initiator methionine residue (Farazi et al., 2001). Some isoforms of KChIPs 2, 3 and 
4 have putative palmitoylation sites instead (Takimoto et al., 2002). Myristoylation
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and indeed palmitoylation would be predicted to enable interaction with membranes 
or hydrophobic domains of other proteins, and play an important role in the 
intracellular targeting of the proteins. Biochemical and structural analyses of 
myristoylated recoverin gave rise to the idea of the Ca2+-myristoyl switch, where in 
the Ca2+-free form of recoverin, the myristoyl group is located within a hydrophobic 
pocket, meaning that the protein remains cytosolic. However, upon Ca binding a 
conformational change occurs which results in the extrusion of the myristoyl group 
thus enabling membrane association of the protein (figure 4) (Ames et al., 1995; 
Tanaka et al., 1995; Ames et al., 1997). Several NCS proteins have also been shown 
to possess a Ca2+-myristoyl switch including hippocalcin (O'Callaghan et al., 2002; 
O'Callaghan et al., 2003b), neurocalcin 8 (Ivings et al., 2002), VILIP-1 (Spilker et 
al., 2002a; Spilker et al., 2002b), and VILIP-3 (Spilker & Braunewell, 2003). Other 
NCS proteins however do not possess this switch mechanism (O'Callaghan & 
Burgoyne, 2003). NCS-1 and KChIPl for instance do not exhibit a Ca2+ -myristoyl 
switch mechanism but have their myristoyl tails constantly exposed and are 
anchored to membranes independently of Ca (O'Callaghan et al., 2002; 
O'Callaghan et al., 2003a) Further to the membrane association of the NCS 
proteins by the myristoyl group, residues within the myristoylation motif can also 
determine intracellular localisation of the NCS proteins, as is the case with KChIPl 
which is localised to post-ER transport vesicles (O'Callaghan & Burgoyne, 2004).
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Figure 3. The crystal structure of NCS-1, a member of the NCS protein family.
The green spheres represent Ca2+ ions bound to EF hand domains 2-4. The N - 
terminal myristoyl group is shown at the base of the protein and it is this group that 
can interact with cell membranes and hydrophobic domains of proteins. KChIPs 2-4 
lack this myristoyl tail as they do not have the necessary glycine at position two and 
instead they contain palmitoylated cysteines in their N-terminal domains which 
contribute to their cell surface localisation.
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Figure 4. The Ca2+/myristoyl switch in recoverin.
(A) Ribbon structure of recoverin without Ca2+ bound. In the absence of Ca2+ the 
N-terminal myristoyl group is folded into the protein. (B) Structure of recoverin 
with Ca2+ binding to EF-hands 2 and 3 (Ca2+ ions represented as green spheres). 
A conformational change is induced by Ca2+ binding, allowing the extrusion of 
the myristoyl tail. (C) The exposed myristoyl group can then interact with the 
lipid bilayer making up membranes.
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1.2.2 Class A: Neuronal Calcium Sensor (NCS) -1
NCS-1 was originally discovered as frequenin in Drosophila melanogaster (Pongs et 
al., 1993) and named after the effect seen due to its overexpression -  it caused an 
enhanced, frequency dependent facilitation of neurotransmitter release at the 
neuromuscular junctions of transgenic fruit flies that resulted in a Shaker-like 
phenotype, characterised by abnormally large responses to repeated stimulation. 
Frequenin was subsequently named NCS-1 as it was thought to only be expressed in 
neuronal cell types (Nef et al., 1995). This is not the case however, and it is, in fact, 
the most widely expressed of all the NCS proteins (McFerran et al., 1998; Kapp- 
Bamea et al., 2003; Gierke et al., 2004). It is, in evolutional terms, the most ancient 
of the NCS proteins, with an orthologue of NCS-1 existing in Saccharomyces 
cerevisiae. This orthologue shares 60% identity to the human protein, and is 
essential for survival in yeast (Hendricks et al., 1999).
NCS-1 has been implicated in multiple cellular functions from studies in both lower 
organisms and in mammalian cells (Burgoyne et al., 2004), including stimulation of 
constitutive (Haynes et al., 2005) and regulated exocytosis (McFerran et al., 1998), 
regulation of neurotransmission (Pongs et al., 1993), learning (Gomez et al., 2001), 
short-term plasticity (Sippy et al., 2003), regulation of both Kv4 (Nakamura et al., 
2001; Guo et al., 2002) and Ca2+ channels (Weiss et al., 2000; Tsujimoto et al., 
2002), neuronal growth (Hui et al., 2006) and survival (Nakamura et al., 2006), 
phosphoinositide metabolism (Hendricks et al., 1999; Zhao et al., 2001; Koizumi et
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a l, 2002; Haynes et a l, 2005) GDNF signalling (Wang et a l, 2001a), and dopamine 
D2 receptor endocytosis (Kabbani et a l, 2002). The latter in particular has been 
linked to schizophrenia and bipolar disorder, where levels of NCS-1 have been 
found to be significantly elevated, although other functions of NCS-1 may also 
underlie these pathophysiological conditions (Bergson et a l, 2003; Koh et al,
2003). Furthermore, NCS-1 has been found to interact with interleukin-1 receptor 
accessory protein-like (IL1RAPL) protein, which has been suggested to have a role 
in X-linked mental retardation (Bahi et a l, 2003).
A significant contribution to the understanding of frequenin/NCS-l function was the 
discovery that in yeast it is essential for survival because it is involved in the 
activation of phosphatidylinositol-4-OH (PI(4)K) Pikl, which is responsible for the 
synthesis of phosphatidylinositol-4-phosphate [PtdIns(4)P], the precursor of 
phosphatidylinositol 4,5-bisphosphate [PtdIns(4,5)P2] (Hendricks et a l, 1999). 
Subsequently it was shown that NCS-1 interacts with the mammalian Pikl 
homologue PI(4)KP type III (Weisz et a l, 2000). By enhancing the activity of these 
enzymes, frequenin/NCS-l can up-regulate InsP3-dependent signalling and Ca 
mobilisation, which is thought to be the underlying mechanism for its ability to 
increase exocytosis or synaptic transmission (Koizumi et a l, 2002; Rajebhosale et 
a l, 2003; Zheng et a l, 2005). Knockout of the gene for NCS-1 is not lethal in other 
organisms, but does lead to developmental phenotypes, including changes in the rate 
of development in Dictyostelium discoideum (Coukell et a l, 2004), impairment of 
memory and learning in C-elegans (Gomez et a l, 2001), and abolishment of the
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formation of the semicircular canals in the inner ear in zebrafish (Blasiole et al.,
2005) .
However, whilst the regulation of PI(4)K0 type III can explain some of the 
functional roles of NCS-1, another key aspect of NCS-1 is its ability to bind to, and 
regulate, multiple target proteins that are unrelated to one another (Haynes et al.,
2006) . Interactions of NCS-1 with different target proteins can involve distinct 
regions of NCS-1 (Kabbani et al., 2002; Bahi et al., 2003), and some of the 
interactions can be independent of Ca2+binding (Kabbani et al., 2002; Haynes et al., 
2006). The significance of these interactions and the various physiological roles of 
NCS-1 are still yet to be fully elucidated.
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1.2.3 Class B: Visinin-like proteins (VILIPS), neurocalcin ô and hippocalcin
The class B NCS proteins are all closely similar in sequence, sharing between 66 
and 94% sequence identity between one another (figure 5). Originally, VILIP-3 and 
neurocalcin 5 were actually considered to be the same protein expressed in different 
species until they were identified as two distinct proteins, though sharing a great deal 
of sequence homology (91% homology between sequences) (Wang et a l, 2001b; 
Spilker et a l, 2002b). All have been demonstrated to exhibit a Ca2+/myristoyl 
switch, with the exception of VILIP-2, and as such will translocate from the cytosol 
to membranes in a Ca2+-dependent manner (Ivings et a l, 2002; O'Callaghan et a l, 
2002; Spilker et a l, 2002a; Spilker et a l, 2002b; O'Callaghan et a l, 2003b; Spilker 
& Braunewell, 2003). However, the physiological functions of most of these 
proteins are still somewhat unclear.
Perhaps the most studied of the class B proteins is hippocalcin, which has a 
relatively specific distribution to hippocampal neurons and was suggested to be 
involved in long term potentiation (LTP) (Kobayashi et a l, 1993). Work in 
hippocalcin knock-out mice has backed up this theory, with the mice found to have 
deficiencies in learning (Kobayashi et a l, 2005). However, this is not the only 
physiological role it has been implicated as being involved in. Hippocalcin has also 
been suggested to be anti-apoptotic, having neuroprotective effects when, at high 
Ca2+ concentrations, it interacts with neuronal apoptosis inhibitory protein (NAIP) 
enhancing its inhibitory effects on cell death (Mercer et a l, 2000; Lindholm et a l,
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2002). Furthermore, it has been demonstrated to influence caspase-12 activation 
(Korhonen et al., 2005). A role in long term depression (LTD) has been suggested, 
where hippocalcin is believed to be involved in the recycling of AMPA receptors 
through an interaction with the 02 clathrin adapter protein (Palmer et al., 2005), as 
well as having an involvement in Ca2+ -dependent phospholipase D (PLD) activation 
(Hyun et al., 2000) and mitogen-activated protein kinase (MAPK) signalling 
pathways (Nagata et al., 1998; Oh et al., 2006). More recently, it has been 
demonstrated to interact with Ca2+ -dependent activator protein for secretion 1 
(CAPS1) and CaM-dependent cyclic nucleotide 3’, 5’, phosphodiesterase (Haynes et 
al., 2006). However, the precise functional role of hippocalcin is still yet to be fully 
defined.
Relatively little meanwhile, is know about the VILIPs. Indeed, only a modest 
amount of research has been published on VILIPs 2 and 3, with VILIP2 thought to 
be involved in the regulation of P/Q type Ca channels (Few et al., 2005; 
Lautermilch et al., 2005) and the functional role of VILIP3 still unknown. More 
research has however, been carried out on the remaining VILIP. VILIP1 has a 
proposed role in the pathophysiology of Alzheimer’s disease due to its association 
with amyloid plaques and neurofibrillar tangles in the brains of Alzheimer sufferers,
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and its influence of Ca -mediated neurotoxicity and phosphorylation of tau protein 
(Schnurra et al., 2001). It has also been shown to interact with and activate guanylyl 
cyclases, affect the traffic of both nicotinic receptors (Lin et al., 2002)and guanylyl
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cyclase receptors (Brackmann et al., 2005), and increase intracellular cAMP levels 
resulting in an effect on secretion (Dai et al., 2006).
Similarly, very little is known about the functions of neurocalcin 5. A role in 
guanylyl cyclase activation has been proposed (Krishnan et al., 2004), and 
interactions with several other proteins have been demonstrated including CAPS1 
and CaM-dependent cyclic nucleotide 3’,5’, phosphodiesterase (Haynes et al., 
2006), clathrin heavy chain (Ivings et al., 2002), and actin and tubulins (Momet & 
Bonet-Kerrache, 2001; Ivings et al., 2002). Clearly however, a great deal more 
investigation is required before the functional roles of the class B NCS proteins are 
fully understood.
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Figure 5. Alignment of the sequences of the Class B NCS family members.
Sequence alignments were carried out utilising Geneious Pro v.3.5.6 
software. Amino acids are colour coded based on their hydrophobicity.
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1.2.4 Class C: Recoverin
Recoverin was the first of the NCS proteins to be discovered (Dizhoor et al., 1991).
It is expressed solely in retinal photoreceptors where it plays an important role in 
light adaptation, inhibiting rhodopsin kinase in the dark when Ca2+ levels are high 
and downregulating this inhibition when the Ca2+levels fall (Kawamura et al., 1993; 
Chen et al., 1995; Palczewski et al., 2000). By inhibiting rhodopsin kinase, 
phosphorylation of rhodopsin and its inactivation is effectively downregulated by 
recoverin. As a result, rhodopsin activation in the dark is prolonged by recoverin, 
allowing retinal photoreceptors to adapt to the lack of light and develop an increased 
sensitivity at low light levels (Makino et al., 2004).
The structure of recoverin, in both its Ca2+ -bound and Ca2+ -free forms, has been 
extensively studied and led to the establishment of the Ca /myristoyl switch model 
(Dizhoor et al., 1992; Dizhoor et al., 1993; Ames et al., 1994; Ames et al., 1995; 
Tanaka et al., 1995; Ames et al., 1997). In its Ca -free form, the myristoyl group 
of recoverin is sequestered in a hydrophobic pocket within the protein, with the 
protein itself being cytosolic (Tanaka et al., 1995). Sequential binding of Ca to 
EF-hand 3 followed by EF-hand 2 (Ames et al., 2002; Ames & Ikura, 2002; Senin et 
al., 2002; Weiergraber et al., 2003) results in a significant conformational change to 
the protein involving a 45-degree rotation of the amino-terminal domain relative to 
the carboxy-terminal domain, resulting in both the exposure of hydrophobic residues 
(enabling them to interact with a target) and the extrusion of the myristoyl group,
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that is then available for interaction with membranes (figure 4) (Zozulya & Stryer, 
1992; Ames et al., 1997). The Ca2+/myristoyl switch enables recoverin to associate 
with target membranes in a Ca2+-dependent manner, and is particularly important for 
recoverin in the Ca2+-dependent regulation of rhodopsin kinase (Senin et al., 1995). 
Apart from recoverin, only the class B proteins also exhibit the Ca /myristoyl 
switch, with other members of the NCS family using their myristoyl group for 
constitutive membrane association instead (Olshevskaya et al., 1997; O'Callaghan et 
al., 2002; O'Callaghan & Burgoyne, 2003; O'Callaghan et al., 2003a).
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As with recoverin, the guanylate cyclase activating proteins (GCAPs) are expressed 
only in photoreceptor cells, where they play a specific role in light adaptation during 
phototransduction, regulating retinal guanylyl cyclases 1 and 2 through a calcium 
feedback mechanism (Palczewski et a l, 2000; Palczewski et a l, 2004). There are 
three genes that encode GCAPs in the human genome (Palczewski et a l, 1994; 
Dizhoor et a l, 1995; Haeseleer et a l, 1999), with GCAPs 1 and 2 found expressed 
in both rod and cone photoreceptors in the human retina (Palczewski et al., 2004). 
GCAP3 is expressed only in cones, although this is not the case in mice, suggesting 
that the protein is non-essential for normal vision (Imanishi et a l, 2002).
When photoreceptor cells are illuminated, the resultant lower Ca level causes the 
GCAPs to act to increase the activity of retina-specific membrane-bound guanylate 
cyclases for resynthesis of cGMP. As the cGMP levels increase, cation channels re­
open and this aids the recovery of the photoreceptor cell to the dark state. When 
retinal Ca levels are elevated, GCAPs 2 and 3 act to inhibit guanylyl cyclase 
activity to below basal level (Gorczyca et a l, 1995; Dizhoor & Hurley, 1996).
The importance of the GCAPs has been illustrated by studies on mutations in human 
GCAP1 that found that these mutations can lead to the degeneration of 
photoreceptors (Dizhoor et a l, 1998; Newbold et a l, 2001). GCAPs 1 and 2 are 
both present in the retina at similar concentrations (Hwang et a l, 2003), and whilst
1.2.5 Class D: Guanylate cyclase activating proteins (GCAPs)
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both have been demonstrated to regulate both of the guanylyl cyclases, they seem to 
interact with them in different ways (Hwang et a l, 2003), share only a 49% 
sequence homology and differ significantly in their Ca2+ -binding affinities for 
retinal guanylyl cyclase activation (Hwang et a l, 2003; Peshenko & Dizhoor, 2004; 
Peshenko et a l, 2004). However, expressing Gcaplin mice that lack both Gcapl 
and Gcap2 recovers almost all normal function in rods and cones (Howes et al., 
2002; Pennesi et a l, 2003).
Like most other NCS protein family members, the GCAPs are N-terminally 
myristoylated, although a clear role for this myristoylation has only recently been 
established. Myristoylation is apparently important for the optimal interaction of 
GCAP1 with its membrane-bound target guanylyl cyclase 1 (Schrem et a l, 1999). 
GCAP2 on the other hand, whilst bound to membranes at low Ca levels and 
dissociated from them at higher concentrations, does not require myristoylation for 
either its membrane association or its stimulation of guanylyl cyclases, and it does 
not possess the Ca /myristoyl switch mechanism (Olshevskaya et a l, 1997). Thus 
it is believed that the myristoyl group present on the GCAPs is important in the fine 
tuning of guanylyl cyclase activity and in target recognition (Hwang & Koch, 2002b, 
a). Recent work has shown that the myristoyl group of GCAP1 is always buried 
within the protein even in the Ca -bound state and its role is in the maintenance of 
the overall folding and stability of GCAP1 (Stephen et a l, 2007).
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The most recently discovered of the NCS proteins, the potassium channel interacting 
proteins (KChIPs), were found as a sub-family through a yeast two hybrid screen 
using the N-terminus of the Kv4.3 potassium channel protein as bait (An et al.,
2000) with one KChEP found independently in other studies and named DREAM 
(Carrion et al., 1999) or calsenilin (Buxbaum et al., 1998). The KChIP class has 
become the most diversified of the NCS protein family throughout evolution, with 
four KChIP genes present in mammals and a large number of potential splice 
variants. Currently, 16 different KChIP isoforms have been found to be detectably 
expressed, and whilst most are found in the brain, some of the KChIP2 isoforms are 
only found in the heart and KChIP3 has also been found to be expressed in the testes 
(An et al., 2000; Kuo et al., 2001; Patel et al., 2002; Pruunsild & Timmusk, 2005).
The C-terminal EF-hand domains of the human isoforms of the KChIPs are at least 
70% identical to each other, with their variable N-terminal extensions forming the 
key difference between the splice variants (figure 6). KChIP 1 is the only member of 
the subfamily that has the glycine at position two required for myristoylation. The 
myristoyl group of KChIP 1 is exposed irregardless of Ca2+binding status and this 
myristoyl tail anchors the protein to intracellular membranes (O'Callaghan et al., 
2003a). The other three KChIP subtypes are not myristoylated, though the three 
longer isoforms of KChIP2 (KChIP 2.1,2.2 and 2.3), and the longest isoforms of 
both KChIP3 (KChIP3.1) and KChIP4 (KCMP4.1) are palmitoylated through
1.2.6 Class E: Potassium Channel Interacting Proteins (KChIPs)
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Figure 6. Alignment of the sequences of isoforms of the four KChIP protein 
members examined in this project.
The isoforms shown in the alignment are KChIP1.2, KChIP2.3, KChIP3.1 and 
KChIP4.1. Sequence alignments were carried out utilising Geneious Pro v.3.5.6 
software. Amino acids are colour coded based on their hydrophobicity.
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cysteines in their N-terminal domains. Palmitoylation of KChIPs 2.3 and 3.1 is 
required for efficient trafficking of Kv4 channels, and only palmitoylated KChEP2 
associates with the plasma membrane when expressed alone (Rosati et al., 2001; 
Takimoto et al., 2002; Shibata et al., 2003). Each of the KChIPs appear to have a 
cell-type specific expression in the brain suggesting that each neuronal cell type 
expresses only a limited number of KChIP isoforms (Rhodes et al., 2004).
One subfamily of proteins, multiple functions
Whilst the KChIPs were originally discovered as a group of proteins that interact 
with the Kv4 potassium channels (An et al., 2000), subsequent research has found 
that the KChIPs can actually carry out multiple cellular functions. This multiple 
functionality was identified initially following the realisation that KChIP3 had been 
identified previously and assigned other functions which have now been 
substantiated.
KChIP3/Calsenilin/DREAM
Amongst the KChIPs, KChIP3 is of particular interest as it has three well established 
but totally unrelated functions. As a result, this protein has been given three 
different names. It was named KChIP3 based on its ability, along with KChIPs 1, 2 
and 4, to regulate certain K+ channels (An et al., 2000), calsenilin due to its 
interaction with the presenilin proteins (Buxbaum et al., 1998) and DREAM based 
on its ability to repress gene transcription through binding to the DRE DNA motif
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(Carrion et al., 1999). For the purposes of this investigation and to avoid confusion, 
I will henceforth refer to this protein as KChIP3.
As KChIP3 is involved in three distinct biological pathways, it is likely that this 
protein performs multiple functions that are mediated through specific interactions 
with proteins in different cell compartments. In cultured cells and mammalian brain 
extracts, the majority of KChIP3 is found in the cytoplasmic fraction although it is 
also tightly associated with the membrane fraction (Choi et al., 2001; Zaidi et al., 
2002) This localisation is in agreement with the ability of KChIP3/calsenilin to 
interact with the presenilins and the Kv4 channel proteins located in the ER, Golgi 
and/or the plasma membrane. It has also been shown that KChIP3 can also 
translocate from the cytoplasm to the nucleus in order to act as a transcriptional 
repressor, with this translocation from the cytoplasm to the nucleus modulated by 
the levels of intracellular calcium, though this effect does not appear to be mediated 
through the direct binding of calcium to KChIP3 (Zaidi et al., 2004). Given that 
KChIP3 is localised to several different compartments of the cell, many questions 
regarding the mechanisms regulating its activity still need to be addressed.
Recent work has concerned KChIP3 in a variety of roles, including its involvement 
in pain modulation(Cheng et al., 2002), apoptosis (Jo et al., 2001; Jo et al., 2003), 
epileptic seizure (Hong et al., 2003), development (Stetsyuk et al., 2007) and long 
term potentiation (Lilliehook et al., 2003), although the precise mechanisms 
involved in each are yet to be fully elucidated, particularly with respect to its
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interaction with the presenilins. KChIP3 has also been shown to stimulate apoptosis 
(Jo et al., 2001; Jo et al., 2004) and processing of the (3-amyloid precursor protein 
(Lilliehook et al., 2003), both of which are linked to Alzheimer’s disease.
Furthermore, KChIP3 has been implicated in having a role in epilepsy, as after 
kainic acid-induced seizure in mice and using a cell-culture model of seizure-like 
activity, KChIP3 expression was markedly decreased, suggesting that it may 
functionally be associated with the pathophysiology of status epilepticus (Hong et 
al., 2003).
So whilst KChIP3 has been implicated as having an important role in multiple 
neurological functions and disorders including Alzheimer’s Disease, its precise 
function and role within the cell has not been well characterised. It is the ability of 
KChIP3 to perform multiple cellular functions, and the potential for the other 
KChIPs to act in a similar manner that form the major basis for this investigation.
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1.3 The Known Functions of the KChIPs
1.3.1 Kv4 Potassium Channels and their regulation by the KChIPs
The mammalian Kv4 subfamily of channels is one of the nine currently identified 
subfamilies of voltage gated K+ channels (Kvl-9) (O'Grady & Lee, 2005), and was 
originally discovered as the ‘Shal’ gene in Drosophila (Butler et al., 1990; 
Covarrubias et a l, 1991; Pak et al., 1991). The Kv4 channel carries a transient, A- 
type K+ current, controlling the excitability of neurons and cardiac myocytes by 
regulating the neuronal firing frequency, preventing the back propagation of action 
potentials into neuronal dendrites and underlying the early phase of repolarisation in 
cardiac myocytes (Serodio et al., 1994; Dixon et al., 1996; Hoffman et al., 1997; 
Serodio & Rudy, 1998; Dilks et al., 1999). At the present time, three mammalian 
Kv4 genes have been identified by molecular cloning, Kv4.1-4.3 (Pak et al., 1991; 
Serodio et al., 1996; Isbrandt et al., 2000), with two isoforms of Kv4.3 present in 
mammals due to alternative splicing (Kv4.3 long and Kv4.3 short) (Ohya et al., 
1997; Dilks etal., 1999).
Voltage gated K+ channels consist of a tetrameric core of pore forming a-subunits, 
with their individual functional properties, turnover rates and intracellular traffic 
modulated by interactions with other proteins (Jan & Jan, 1997; Choe et al., 1999). 
Each a-subunit is composed of 6 transmembrane domains, S1-S6, and cytoplasmic 
amino- and carboxy-terminal domains (figure 7) (Bimbaum et al., 2004).
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Figure 7. Schematic drawing of a Kv4 channel subunit.
Each a-subunit is composed of 6 transmembrane domains, SI-6, and 
cytoplasmic amino- and carboxy-terminal domains. KChIP binds to the N-terminus. 
The hydrophobic P segment, together with the adjacent S5 and S6 segments form the 
channel pore through which potassium ions are conducted. S4 carries positive 
charges and acts as the voltage sensor. Four subunits assemble to form a functional 
channel. Adapted and modified from Bimbaum et al, 2004.
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When four a-subunits are arranged to form a tetrameric Kv channel, each 
hydrophobic P-loop between regions S5 and S6 forms a quarter of the ion 
conduction pathway, with the P-domain from each individual a-subunit facing one 
another to form the channel pore. As the S5 and S6 segments also align the pore of 
the channel, this allows the formation of an electrochemical gradient that allows K+ 
ions to travel along this conduction pathway and across the cell membrane (Jemg et 
a l, 2004). The S4 domain acts as the voltage sensor of the channel, with membrane 
depolarisation triggering movement in the S4 segment leading to activation or 
opening of the channel. Similarly, during deactivation, the segments rearrange to 
close the channel (Robertson, 1997). The cytoplasmic N- and C-terminal regions of 
the a-subunits also carry out important roles. For example, the proximal N-terminal 
region (amino acids 71-90) mediates the specific binding of the KChIPs (Bahring et 
a l, 2001b; Scannevin et a l, 2004; Zhou et a l, 2004) whilst the C-terminus mediates 
interactions with a variety of regulatory proteins, including PSD-95 (Wong et al., 
2002) and KvP subunits (Yang et a l, 2001). In addition, the N-terminus is involved 
in mediating the specificity of subfamily association through its so-called 
tetramerisation domain, meaning that four a-subunits from the Kv4 subfamily 
associate with one another, but not with other Kv subfamilies (Kukuljan et a l,
1995). Furthermore, the N-terminus is involved in the inactivation of the Kv4 
channel (N-type inactivation) (Bahring et a l, 2001a; Gebauer et a l, 2004), with the 
C-terminus also suggested to be involved in inactivation gating (Jemg et a l, 1999).
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Kv4 channels are highly expressed in the brain, as well as in heart and smooth 
muscle (Isbrandt et al., 2000). They can be found throughout the central nervous 
system (CNS), with their expression apparently neuron specific, where they are 
involved in regulating membrane excitability and postsynaptic signal transduction 
(Alonso & Widmer, 1997; Serodio & Rudy, 1998). Kv4 channels inhibit the ability 
of the dendrites to initiate action potentials, effectively dampening dendritic 
excitability and preventing the back propagation of action potentials into neuronal 
dendrites, with this control of dendritic excitability implicated in the induction of 
NMDA receptor-dependent LTP (Watanabe et al., 2002). Kv4 channels have also 
been demonstrated to have a key role in tuning pacemaker activity in dopaminergic 
midbrain neurons, and as a result are involved in control of dopamine release, 
something that has made them potential therapeutic targets for neuronal disorders 
such as Parkinson’s disease and schizophrenia. Kv4 channels are also of interest 
with respect to epilepsy research, as there is a markedly reduced expression of Kv4.2 
associated with this condition that is thought to contribute to the increased neuronal 
excitability that causes the initiation and propagation of seizures (Castro et al., 2001; 
Bernard et al., 2004).
The KChIPs interact directly with Kv4 a-subunits and were first identified through a 
yeast two hybrid screen using the N-terminal region of Kv4.3 as bait. Subsequent 
immunohistochemical and co-immunoprecipitation studies have demonstrated that 
the KChIPs are integral components of native Kv4 channels in the brain (An et al., 
2000; Holmqvist et al., 2002; Morohashi et al., 2002; Rhodes et al., 2004). They
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form an octomeric structure made up of four KChIPs and four Kv4 channel subunits 
(Kim et al., 2004a; Kim et al., 2004b; Pioletti et al., 2006; Wang et al., 2007), as 
illustrated in figure 8.
The first comparative study of the KChIPs and their effects on Kv4 channels 
analysed KChIPsl.2, 2.3 and 3.1 (An et al., 2000) which were all found, albeit with 
some quantitative differences, to demonstrate the same effects: increasing the 
expression of Kv4 at the plasma membrane, shifting the voltage-dependency of 
activation, slowing inactivation and recovering from the inactivation at a faster rate. 
Further work in heterologous expression systems where the Kv4 current was 
measured electrophysiologically, both in the presence and absence of KChIPs, 
confirmed these findings, namely a marked increase in peak amplitude (current 
density) and a slowing of Kv4 inactivation when the channel was co-expressed with 
the KChIPs (figure 8c) (Bahring et al., 2001a; Decher et al., 2001; Beck et al., 2002; 
Hatano et al., 2002; Holmqvist et al., 2002; Morohashi et al., 2002; Decher et al., 
2004). In summary, the KChIPs restore the native-like properties to the Kv4 current 
that are not seen when the Kv4 subunits are expressed alone. And whilst the 
interaction with the Kv4 channels is not reliant on Ca binding, the functional 
activities exhibited by the KChIPs are, as they have been demonstrated to require 
intact EF-hands (An et al., 2000; Morohashi et al., 2002). The interaction of the 
KChIPs with the Kv4 channels is mediated through the C-terminal region of the 
KChIPs, with the variable N-terminal region demonstrated as being non-essential for 
the interaction with the channel and not required for the basic effects on channel
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traffic and gating properties (An et al., 2000). However, it has subsequently become 
clear that the variable N-terminal region of the different KChIP isoforms is 
important in generating the variable effects on Kv4 channels. For example, a 
comparative study on the rate of recovery from inactivation of Kv4 channels when 
co-expressed with the KChIP 1 isoforms 1.1 and 1.2 found significant differences in 
the effects upon the channel (Boland et al., 2003; Van Hoorick et al., 2003). Similar 
differences in the efficiency of traffic of Kv4 channels to the plasma membrane and 
in the modulation of gating properties have also been demonstrated for several 
different KChIP2 and KChIP4 isoforms (Deschenes et al., 2002; Holmqvist et al., 
2002; Morohashi et al., 2002; Patel et al., 2002; Takimoto et al., 2002; Decher et al., 
2004; Patel et al., 2004).
The physiological significance of the KChIPs as modulators of Kv4 channels has 
been illustrated by studies on KChIP knock-out mice. The KChIP2 knock-out 
resulted in a complete loss of the transient outward K+ current that is mediated by 
the Kv4 potassium channels in ventricular myocytes, producing a phenotype highly 
susceptible to cardiac arrhythmias (Kuo et al., 2001). The authors deduced that the 
absence of KChIP2 resulted in a trafficking defect where Kv4 channels no longer 
reached the plasma membrane, meaning that the myocardium became 
hyperexcitable.
35
cFigure 8. The interaction between the KChIPs and Kv4 channel subunits.
(A) View of the octomeric structure formed between four KChIPs and four Kv4.3 
channel subunits. (B) The interaction between KChIPl and the N-terminus of 
Kv4.3. The N-terminus of Kv4.3 is shown in yellow and the green spheres 
represent Ca2+ ions bound to EF-hands 3 and 4. The structure was solved by 
Pioletti et al, 2006. (C) Kv4 currents as measured by
whole-cell patch clamp recording. Co-expression of KChIPl increases the current 
amplitude and slows the inactivation of the K+ channels (from Burgoyne et al, 2004).
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Two studies have been carried out using KChIP3 knock-out mice, although only one 
of the studies investigated the effects on Kv4 channels, where an increase in LTP 
(long term potentiation) was discovered which coincided with a downregulation of 
Kv4 current in the hippocampus (Lilliehook et al., 2003). It is believed that the back 
propagation of action potentials into neuronal dendrites is prevented by activated 
Kv4 channels. However, when Kv4 channels are absent or inactivated, their block 
on the dendritic membranes is absent, allowing incoming EPSPs (excitatory 
postsynaptic potentials) to generate action potentials. An amplification of the 
dendritic action potentials results in the unblocking of NMD A receptors and influx 
of Ca2+that induces LTP (Johnston et al., 2000a; Johnston et al., 2000b).
1.3.2 The DREAM function of the KChIPs
KChIP3 was identified as DREAM (downstream-regulatory-element-antagonist 
modulator) by Carrion and co-workers (Carrion et al., 1999), who demonstrated that 
it can bind to DNA and act as a Ca2+ dependent regulator of transcription. DREAM 
was found to be identical to KChIP3/calsenilin except for the suggested presence of 
30 additional residues at the N-terminus. This was later identified as being a 
mistake, with both sequences found to be identical. It binds as a tetramer to DREs 
(downstream regulatory elements) located downstream of the TATA box in target 
genes (Carrion et al., 1998; Carrion et al., 1999) where it acts to repress 
transcription. Ca2+ binding induces a conformational change in DREAM that 
prevents its binding to these DREs, demonstrated by work carried out on EF-hand 
mutants of DREAM/KChIP3, which were unable to bind Ca2+. DRE residues are 
composed of a single copy or two inverted copies of the sequence GTCA (Ledo et 
al., 2000b). So in summary, DREAM/KChIP3 binds to DREs to repress 
transcription in the absence of Ca , whilst at increased intracellular Ca 
concentrations, its DNA binding and repressor actions are abolished (Osawa et al., 
2001) .
DREAM/KChIP3 can also bind Mg2+ in addition to Ca2+, although the importance of 
Mg2+binding is yet to be clearly defined. It had originally been concluded that it 
was calcium and not magnesium binding that was important in modulating 
DREAM/KChIP3 structure and function (Craig et al., 2002). However, more recent
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studies have suggested that binding of both Ca and Mg are able to induce distinct 
conformational changes, with Mg2+binding at EF2 suggested to structurally bridge 
DREAM/KChIP3 to DNA targets (Osawa et al., 2005).
A number of target genes have been identified for DREAM/KChIP3, including 
prodynorphin, which is involved in memory and pain perception, inducible cAMP 
early repressor (ICER), arylalkylamine N-acetyltransferase (AA-NAT), c-fos and 
Fos-related antigen-2 (fra-2), the apoptotic gene hrk and thyroid-specific 
transcription factors Pax8 and Foxel (Carrion et al., 1999; Ledo et al., 2000a; Sanz 
et al., 2001; Ledo etal., 2002; Sanz et al., 2002; Link et al., 2004; D'Andrea et al., 
2005). More recently it has been found to bind to the promoter of the NCX3 gene 
where it acts to repress transcription of NCX3 (Gomez-Villafuertes et al., 2005). 
The Na+/Ca2+ exchangers NCX1, NCX2 and NCX3 are vital for the control of 
cellular Ca homeostasis in neurons.
The physiological relevance of DREAM/KChIP3 as a transcriptional repressor has 
been demonstrated by studies on DREAM knock-out mice, which were found to 
have increased prodynorphin levels and a decreased pain response. Cheng and 
colleagues found that KChIP3/DREAM acts as a transcriptional repressor involved 
in regulating pain, as KChEPS/DREAM'7" mice displayed markedly reduced 
responses in models of acute thermal, mechanical and visceral pain, as well as 
reduced pain behaviours in models of neuropathic and inflammatory pain. This led 
to the suggestion of DREAM as a therapeutic target for the management of arthritic
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pain (Cheng & Penninger, 2004). At the same time however, these 
KChIPS/DREAM'7' mice showed no major defects in motor function or learning and 
memory (Cheng et al., 2002). However, in another KChIP3/DREAM knock-out 
mouse line, long term potentiation (LTP) in the dentate gyrus of hippocampus, 
where KChIP3 is strongly and selectively expressed, is enhanced (Lilliehook et al., 
2003).
Interestingly, it has subsequently been shown that it is not just DREAM/KChIP3 that 
can bind to DRE sites. Link and co-workers demonstrated that KChlPsl, 2 and 4, in 
addition to KChIP3, can bind to DRE sites located in the regulatory regions of the 
ICER, fra-2 and AA-NAT genes which are involved in circadian rhythms (Link et 
al., 2004). This adds further weight to the argument that the KChIPs can carry out 
multiple, overlapping functions within neuronal populations.
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1.3.3 The KChIPs and the Presenilins
KChIP3 was originally isolated as a presenilin-interacting protein and named 
calsenilin (Buxbaum et al., 1998). It co-immunoprecipitates with both PS1 and PS2 
in transfected cells, as well as at endogenous levels in brain (Buxbaum et al., 1998; 
Choi et al., 2001). KChIP3 binds to the C terminus of both PS1 and PS2, and for this 
reason it has been implicated as potentially having a role in presenilin-associated 
Alzheimer’s disease.
The identification of calsenilin/KChIP3 as an interacting partner of presenilins 1 and 
2 generated a lot of interest, as most early-onset familial Alzheimer disease cases are 
caused by mutations in the highly regulated genes presenilin-1 (PS1) and presenilin- 
2 (PS2) (Selkoe, 1997; Buxbaum et al., 1998). Alzheimer’s is the most common 
cause of senile dementia in humans, and is the fourth leading cause of death in the 
United States (Lendon et al., 1997). These mutations lead to increased P-amyloid 
(AP) formation and apoptosis, with the deposition of AP in the extracellular 
compartments being one of the characteristics of Alzheimer’s, along with the 
formation of neurofibrillary tangles in the neuronal cell body and massive neuronal 
death (Choi et al., 2001; Lilliehook et al., 2002; Jo et al., 2003). To date six 
mutations in PS2 and 75 mutations in PS1 have been reported (Zaidi et al., 2002) 
and although the presenilins have been implicated in having a role in the Notch 
signalling pathway, amyloid precursor protein (APP) processing, calcium 
homeostasis and programmed cell death, their normal physiological roles are still a 
topic of debate. It is hoped that the identification and characterisation of interacting
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partners may ultimately provide a greater insight into the functional role of the 
presenilins.
KChIP3 has generated more interest than sorcin, another presenilin-binding protein 
that may play a role in modulating calcium signalling, as sorcin binds only to PS2 
and not to PS1 (Pack-Chung et al., 2000). Therefore this molecule is unlikely to be 
involved in a general function of the presenilins, linked to the pathogenesis of 
Alzheimer’s disease, whereas KChIP3, which binds to both PS1 and PS2, is in 
contrast more likely to play such a role (Leissring et al., 2000).
The link between calsenilin/KChIP3 and Alzheimer’s disease has been enhanced by 
the discovery of increased levels of calsenilin/KChEP3 protein and mRNA in 
Alzheimer’s disease brains (Jin et al., 2005), and a calsenilin/KChIP3 knock-out 
mouse that exhibited reduced processing of the amyloid precursor protein (APP) 
(Lilliehook et al., 2003). Processing of the APP leads to the formation of amyloid-P 
peptide (AP), the primary component of neuritic (senile) plaques that, along with 
neuronal cell death and the accumulation of neurofibrillary tangles (NFT), 
pathologically characterize Alzheimer’s disease (Price & Sisodia, 1998). AP is 
generated by consecutive proteolytic cleavages mediated by P- and y-secretase, with 
evidence suggesting that presenilins are either the catalytic subunit or a necessary 
co-factor of a high molecular weight multi-subunit aspartyl protease complex that 
exhibits y-secretase activity (Li et al., 2000; Esler et al., 2002), and 
calsenilin/KChIP3 thought to play a role in modulating the presenilin activity
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(Buxbaum, 2004). In cell cultures KChIP3 has been shown to enhance apoptosis by 
increasing the content of intracellular Ca2+ stores (Lilliehook et al., 2002) and 
increasing presenilin-dependent y-secretase cleavage of the Alzheimer disease 
amyloid protein precursor, thereby elevating A0 formation (Jo et al., 2005).
The effect of KChIP3 on the content of intracellular Ca2+ stores is particularly 
interesting, as recent studies have suggested that the presenilins may act within the 
cell as ER Ca2+leak channels (Tu et al., 2006; Nelson et al., 2007). Ca2+ signalling 
defects have been observed by numerous groups studying FAD, including studies 
with fibroblasts from FAD patients (Ito et al., 1994), in FAD cellular and animal 
models (LaFerla, 2002; Smith et al., 2005) and in cells from presenilin knockout 
mice (Herms et al., 2003; Ris et al., 2003; Takeda et al., 2005). A number of 
hypotheses have previously been suggested to explain these phenomena, notably 
including regulation of expression of neuronal Ca signalling proteins (Leissring et 
al., 2002) and the proposal that the presenilins act as ER Ca leak channels (Tu et 
al., 2006). In the case of the latter, it is thought that in order to maintain a steady- 
state ER intraluminal Ca level, an equilibrium develops between SERCA-mediated 
movement of Ca2+ from the cytosol into the ER lumen and the passive leak of Ca2+ 
from the ER into the cytosol through low-conductance divalent-cation-permeable 
ion channels formed by the presenilins. This is supported by the fact that the ER 
Ca2+ leak is abolished by the expression of presenilin mutants, with the authors 
suggesting that the disruption of the ER Ca leak pathway may lead to Ca 
overloading of the ER and that this disturbed Ca2+homeostasis ultimately
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contributes to Alzheimer disease pathogenesis (Nelson et al., 2007). Thus both 
increased expression of KChIP3 and mutations in the presenilins, both found in 
Alzheimer’s disease patients, may cause Ca overloading of the ER resulting in 
cellular damage.
Presenilin activity itself has been shown to regulate calsenilin/KChIP3-mediated 
apoptosis, suggesting a combined role for the presenilins and calsenilin/KChIP3 in 
the neuronal cell death seen in Alzheimer’s disease (Jo et al., 2003). Furthermore, 
calsenilin/KChIP3 has been shown to be a substrate for caspase-3, and may not only 
play a role in increased ER Ca loading, but also facilitate Ca release from the ER, 
which is consistent with a role in apoptosis (Leissring et al., 2000; Choi et al., 2001; 
Lilliehook et al., 2002; Choi et al., 2003).
However, the exact contribution of apoptosis to the pathogenesis of the disease 
remains unclear, as does the role of KChIP3 and its interaction with the presenilins, 
although it has though been shown that in KChIP3 knock-out mice, there is a 
reduction in A0 formation (Lilliehook et al., 2003). A|3 formation is believed to 
have a role in apoptosis, with KChIP3 thought to play an important role, possibly 
increasing A0 formation by modulating y-secretase activity through interaction with 
presenilin (Jo et al., 2001), although it has also been speculated that the pro- 
apoptotic effect of KChIP3 may be due to it acting as a potassium channel regulator, 
as efflux of K+ has been suggested to contribute to neuronal apoptosis (Yu et al., 
1997). Blocking KChIP3 expression has also been shown to protect neuronal cells
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from A(3 toxicity (Jo et al., 2003), again suggesting that its pro-apoptotic effect may 
be due to its role in A0 formation. It is also possible that modifications in 
intracellular Ca2+ signalling by both KChIP3 and mutant presenilins may contribute 
to cellular apoptosis.
The precise significance of the interaction between calsenilin/KChIP3 and the 
presenilins, and how this relates to their functional roles is something that is yet to 
be completely understood. A summary of the current suggested role of the KChIP3- 
presenilin interaction is shown in figure 9. Again, as with the Kv4 channel 
regulation and DRE binding properties, this particular function does not appear to be 
limited to just one of the KChIPs, with at least KChIP4, in addition to KChIP3, able 
to interact with presenilin-2 (Morohashi et al., 2002), once more suggesting the 
potential for the KChIPs to carry out similar cellular roles in different neuronal 
populations.
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Regulation of expression
Figure 9. The current proposed mechanism for the role of calsenilin/KChIP3 in 
Alzheimer’s disease.
Up-regulation of calsenilin/KChIP3 leads to increased binding with presenilin, 
which in turn stimulates cleavage of APP as well as causing cell death. APP 
cleavage leads to A(3 generation, which can then feedback in a positive loop, 
stimulating further calsenilin/KChIP3 production, increasing intracellular Ca2+ 
and down-regulating VILIP-1 expression which in turn also leads to cell death 
and tau phosphorylation.
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1.4 Aims and Objectives
The first major focus of this study was on the KChIP subfamily of the NCS proteins 
and their multiple functional roles. Do the KChIPs simply carry out the same 
functional roles in different neuronal populations, or do they maintain unique 
properties enabling them to carry out individual cellular roles? In order to 
investigate this, I aimed to carry out a comparative study of selected isoforms of 
KChIPs 1-4 and some of their known functions. One of these has been reported 
for all four KChIPs (regulation of Kv4 channels) whilst the others may be specific 
for particular KChIPs (regulation of Kvl .5 channels -  KChIP2, interaction with 
presenilins -  KChIPs 3 and 4). This work utilised fluorescently-tagged versions of 
the proteins, with the intrinsic targeting of each of the proteins expressed 
individually determined first, followed by co-expression studies of the KChIPs with 
the various interacting proteins. The investigation also included NCS-1, as this 
protein is also known to carry out multiple cellular functions, some of which 
reportedly overlap with the functions of the KChIPs. Given this reported overlap 
in function, another aim of my project was to see if the KChIPs can perform 
another established function of NCS-1, its ability to affect secretion, utilising a 
well established essay. It was also aimed to elucidate some of the intracellular 
roles the KChIPs carry out by investigating how they affect Ca2+ signalling 
within the cell.
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CHAPTER 2:
Materials and Methods
2.1 General Reagents
Unless stated differently, all general chemicals were obtained from Sigma-Aldrich 
(Dorset, UK). Consumerables such as tips, cell culture flasks and plasticware were 
provided by Appleton Woods (Birmingham, UK). Glass coverslips and poly-D- 
lysine coated plates were obtained from VWR (Lutterworth, UK).
2.2 Plasmids
Unless otherwise stated, the KChEP splice variants used in the following constructs 
were KChIP1.2, KCMP2.3, KCMP3.1 and KCMP4.1. All KChIP isoforms used are 
human, with the GenBank accession numbers as follows: DQ148477 (1.2), 
DQ148481 (2.3), DQ148485 (3.1) and DQ148487 (4.1). Fluorescent vectors were 
obtained from Clontech (California, USA), the pFLAG-CMV-4 vector from Sigma 
(USA) and the pcDNA3.1 (+) vector from Invitrogen (Paisley, UK).
2.2.1 Fluorescent Constructs
The KChIP2-ECFP construct (pKChIP2-ECFP) was made by inserting the human 
KChIP2 sequence into the pECFP-Nl vector (Clontech, California, USA). The 
human KChIP2 sequence was amplified from an existing KChIP2-pcDNA construct, 
kindly provided by Dr. Robert Bähring (Bahring et al., 2001b), with the primers 
used to facilitate this cloning as follows (endonuclease sites underlined): the sense
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primer was 5 ’ -ACTCAGATCTCAGGATGCGGGGCCAGGGCCGC-3 ’ (Bglll) 
whilst the antisense primer was 5’-TACCGTCGACTGGATGACATTGTCAAA 
GAG-3’ (Sail).
The KChIP3-ECFP construct (pKChIP3-ECFP) was made by inserting the human 
KChIP3 sequence into the pECFP-Nl vector (Clontech, California, USA). The 
human KChIP3 sequence was amplified from an existing EYFP tagged KChIP3 
fusion (pKChIP3-EYFP) construct kindly provided by D. O’Callaghan. The primers 
contained endonuclease sites to facilitate this cloning (underlined). The sense 
primer used was 5 ’-ACTCAGATCTCAGGATGCAGCCGGCTAAGGAA-3 ’ 
(Bglll) and the antisense primer was 5’-TGCAGAATTCCGATGACATTCTCAAA 
CAGC-3’ (EcoRI). Subsequently a new KChIP3-EYFP (pKChIP3-EYFP) construct 
was made by replacing the ECFP tag of the KChIP3-ECFP fusion construct 
(pKChIP3-ECFP) with the EYFP tag of the pEYFP-Nl vector (Clontech, California, 
USA).
The KChIP4-ECFP construct (pKChIP4-ECFP) was made by insertion of the 
KChDM sequence, amplified by PCR from a human KChIP4 cDNA clone (OriGene, 
Rocksville, USA), into the pECFP-Nl vector (Clontech, California, USA). The 
primers used contained the following endonuclease sites (underlined) to enable the 
cloning: the sense primer was 5 ’- ACTCAGATCTCAGGATGAATGTGAGGAGG 
GTG-3’ (Bglll) whilst the antisense primer was 5’-TACCGTCGACTGAATCACA 
TTTTCAAAGAG-3’ (Sail).
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2.2.2 pcDNA constructs
The pcDNA-KChIP3 construct was made by the insertion of the KChIP3 sequence, 
amplified from the pKChIP3-EYFP plasmid by PCR, into the pcDNA3.1 (+) vector 
(Invitrogen). The primers used contained the following endonuclease sites 
(underlined): the sense primer used was 5’-CTTCGAATTCAGGATGCAGCCGG 
CTAAGGAA-3’ (EcoRI) and the antisense primer was 5’-CAACGCGGCCGCTAG 
ATGACATTCTCAAACAGC-3’ (Notl).
2.2.3 FLAG-tagged constructs
The pFLAG-KChIPl construct was made by the insertion of the KChIPl sequence 
into the pFLAG-CMV-4 Expression vector (Sigma, USA), with the KChIPl 
sequence amplified from an existing KChIPl-ECFP construct (Dr. Burcu Hasdemir). 
The primers contained endonuclease sites (underlined) in order to facilitate the 
cloning. The sense primer was 5’-GCTTGCGGCCGCGAGGATGGGGGCCGTCA 
TGGGC-3’ (Noti) whilst the antisense primer was 5’-TATCAGATCTATTTACAT 
GACATTTTGAAACAG-3’ (Bglll).
The pFLAG-KChIP2 construct was made by the insertion of the KChIP2 sequence, 
amplified from an existing KChIP2-pcDNA construct (a kind gift from Dr. Robert 
Bahring) by PCR, into the pFLAG vector. The primers used were as follows, with 
the endonuclease sites underlined: the sense primer used was 5’-GCTT
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GCGGCCGCGAGGATGCGGGGCCAGGGCCGC-3 ’ (Not!) and the antisense
primer was 5’-TATCAGATCTATCTAGATGACATTGACAAAGAG-3 ’ (Bglll).
The pFLAG-KChIP3 construct was made by the insertion of the KCMP3 sequence, 
amplified from the pKChIP3-EYFP plasmid by PCR, into the pFLAG vector. The 
primers contained endonuclease sites (underlined) to facilitate this cloning. The 
sense primer used was 5 ’ -GCTTGCGGCCGCGAGGATGCAGCCGGCTAAG 
GAA-3’ (Noti) and the antisense primer was 5’-TATCAGATCTCCCTAGAT 
GACATTCTCAAACAGC-3 ’ (Bglll).
The pFLAG-KChIP4 construct was made by insertion of the human KChIP4 
sequence, amplified from a human KChIP4 cDNA clone (OriGene, Rockville, USA) 
by PCR, into the pFLAG vector. The primers used were as follows, with the 
endonuclease sites used to facilitate the cloning underlined: Sense 5’-GCTT 
GCGGCCGCGAGGATGAATGTGAGGGTG-3’ (Noti), antisense 5’-TATC 
AG AT CT ATTT AAAT C AC ATTTT C AAAG AG- 3 ’ (Bglll).
2.2.4 Other constructs used
The EGFP-tagged presenilin-1 fusion construct (PSl-EGFP/pCDNA3.1 Zeo) was a 
kind gift from Dr. Christoph Kaether (Kaether et al., 2002). The PS1 wt in 
pcDNA3.1 Zeo (+) was a gift from Prof. Christian Haass. The EGFP tagged mouse 
Kvl.5 fusion construct (mKvl.5-EGFP) was a kind gift from Dr. Jeanne Nerbonne,
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as were the human Kvl.4 and Kvl.5 fusion constructs (Kvl.4-EGFP, Kvl.5-EGFP) 
(Li et al., 2001; Li et al., 2005).
The KChIPl-ECFP and ECFP-Kv4.2 (pECFP-Kv4.2) constructs were provided by 
Dr. Burcu Hasdemir (Hasdemir et al., 2005). The NCS-l-ECFP construct was 
provided by Dr. Lee Haynes (Haynes et al., 2005).
All primers used in PCR amplification were produced by Genosys Biotechnologies 
(Cambs, UK) whilst the sequences of all these constructs were confirmed by 
sequencing by DBS Genomics (Durham, UK).
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2.3 Cell Culture
2.3.1 Culture and transfection of HeLa and COS-7 cells
HeLa and COS-7 cell cultures were grown in 20 ml Dulbecco’s modified Eagle’s 
medium (Gibco, Paisley, UK) containing 5% foetal calf serum (FCS) (Gibco, 
Paisley, UK) and 1% non-essential amino acids (Gibco, Paisley, UK) and 
maintained at ~1,000,000 cells per 75cm2 flask at 37°C in an atmosphere of 5% CO2. 
16-24 hours prior to transfection, cells were seeded onto glass cover slips in a 24- 
well plate at approximately 40,000 cells per well or approximately 100,000 cells per 
well of a 6 well plate. Cells were then transfected at approaching 50% confluency 
using lOOpl transfection reaction mixture. The transfection mix typically contained 
lpg plasmid DNA (2pg for double transfections), with either 3pi (per pg plasmid 
DNA) Fugene (Roche, UK) or 3 pi (per pg plasmid DNA) GeneJuice (Novagen, 
USA) and was made up to lOOpl with Dulbecco’s modified Eagle’s medium (Gibco, 
Paisley, UK). The transfection reaction mixture was incubated at room temperature 
for 30 minutes before being added drop-wise to the cells. Cells were then 
maintained at 37°C for 16-48 hours before being used in experiments.
54
2.3.2 Culture and transfection of PC12 cells
PC 12 cells were grown in suspension in 20 ml RPM I1640 media (Gibco, Paisley, 
UK) containing 5% foetal calf serum (FCS) (Gibco, Paisley, UK), 10% horse serum 
(HS) (Gibco, Paisley, UK), 100 units/ml penicillin and O.lmg/ml streptomycin 
(Sigma) at 37°C in an atmosphere of 5% CO2. 16-24 hours before transfection, 
freshly trypsinised (Gibco, Paisley, UK) cells were plated onto collagen (Sigma) -  
coated glass cover slips in a 24 well plate at a density of -200,000 cells/well or 
-350,000 cells/well for larger coverslips. Cells were then transfected using lOOpl 
transfection reaction mixture consisting of lpg plasmid DNA, 3 pi LipofectAMINE 
2000 transfection reagent (Invitrogen, Paisley, UK) per pg of plasmid DNA and 
made up to lOOpl in opti-mem (Gibco, Paisley, UK). The transfection mixture was 
incubated at room temperature for 30 minutes before being added drop wise to the 
cells. The cells were then incubated for 4-6 hours at 37°C with the transfection 
reaction mixture, before removing the transfection reaction mixture and replacing 
with growth media. Cells were then maintained at 37°C, 5% CO2 for 16-48 hours 
before being used in experiments.
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2.4 Fluorescence Imaging and Immunofluorescence
2.4.1 Immunofluorescence
For imaging of transfected cells, the cells were washed twice in phosphate buffered 
saline (PBS); 137mM NaCl, 2.7mM KC1, lOmM Na2HP04, 2mM NaH2P04, and 
fixed in PBS containing 4% formaldehyde for 30 minutes. Cells were then washed 
in PBS before air-drying coverslips and mounted on glass slides using antifade 
Vectashield (Vector Laboratories Inc.) or ProLong Gold Antifade (Invitrogen,
USA).
For immunostaining of cells attached to coverslips, these were washed twice in PBS 
before fixation in PBS containing 4% formaldehyde for 30 minutes. The cells were 
incubated in PBT (PBS, 0.1% Triton X-100, 0.3% BSA) for 30 min. The PBT was 
removed and replaced by the primary antibody at the appropriate dilution in PBT 
[anti-FLAG (mouse) 1 in 5000 (Sigma), anti-CSEN (rabbit) 1 in 500 (Chemicon 
International), anti-EGFP (mouse) 1 in 500 (BD Biosciences), anti-PS 1 (goat) 1 in 
100 (Abeam, Cambs, UK)]. The primary antibody was incubated for 1 hour or 
overnight at 4°C, removed and the cells washed three times in PBT. The cells were 
then incubated with the appropriate biotinylated antibody (Amersham, Bucks, UK) 
diluted to 1 in 100 with PBT for 1 hour at room temperature. The secondary 
antibody was removed, the cells washed three times in PBT and the cells then 
incubated in streptavidin-Texas Red (Amersham, Bucks, UK) diluted to 1 in 50 with
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PBT for 30 minutes. Alternatively, after removal of the primary antibody and 
subsequent washing, cells were incubated with the appropriate Dylight 649 
secondary (Pierce, Rockford, USA) diluted to 1 in 250 with PBT for 1 hour at room 
temperature. Cells were then washed three times with PBT. The coverslips were 
air-dried and mounted on glass slides using antifade Vectashield (Vector 
Laboratories Inc.) or ProLong Gold Antifade (Invitrogen).
2.4.2 Confocal laser scanning microscopy
For confocal laser scanning microscopy either a Leica AOBS microscope system 
(Leica, Heidelberg, Germany) or a Leica TCS-SP-MP microscope was utilised to 
examine transfected cells. A 22.11 pm pin hole and 63x water immersion objective 
with a 1.2 numerical aperture was used. For imaging ECFP tagged constructs, cells 
were excited at 430nm and light collected at 460-5 lOnm. EYFP was imaged using 
excitation at 514nm with collection at 534-580nm. EGFP was imaged using 
excitation at 488nm with collection at 500-550nm. Texas red was excited at 543nm 
with light collected at 575-700nm. Dylight 649 was excited at 649nm and light 
collected at 620-720nm. For imaging of live cells, cells were maintained in Krebs 
buffer (20mM HEPES (pH7.4), 145mM NaCl, lOmM glucose, 5mM KC1, 3mM 
CaCl2,1.3mM MgCl2,1.2mM NaH2P04).
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2.5 Immunoblotting
Cells to be used for Western blotting were washed in PBS before lysis in lOOgl 
Laemmli buffer (Sigma). Cell samples were then boiled for 10 minutes. Typically 
20pl of sample was then run on a 4%/10% SDS gel before overnight transfer onto 
nitrocellulose (Whatman, Dassel, Germany). Nitrocellulose blots were washed 
twice with PBS over 15 minutes before blocking with 3% milk in PBS for 45 
minutes. The primary antibody was added at the appropriate dilution in 3% milk in 
PBS [anti-GFP (mouse) 1 in 1000 (BD Biosciences), anti-FLAG (mouse) 1 in 10000 
(Sigma), anti-PS 1 (goat) 1 in 5000 (Abeam), anti-Kv4.2 (rabbit) 1 in 500 (Exalpha 
Biologicals Inc.), anti-pan KChEP potassium channel subunit (mouse) 1 in 1000 (UC 
Davis/NINDS/NIMH NeuroMab Facility, CA, USA)]. The primary antibody was 
added for 1 hour at room temperature (or overnight at 4°C), removed and the blot 
washed three times in PBS. The blot was then incubated with the appropriate HRP- 
conjugated secondary antibody (Sigma) diluted to 1 in 400 in 3% milk, 0.5% Tween, 
in PBS for 1 hour. The blot was washed once in PBS containing 0.5% Tween, 
washed 3 times in PBS, once in 0.3M NaCl in PBS for 30 minutes and once in dFUO 
for 15 minutes. The appropriate ECL reagents (Amersham, Bucks, UK) were then 
added for 1 minute, the blot dried and covered in cling film before exposure to 
hyperfilm ECL for 1 minute. The film was developed in D19 developer for 1 
minute, rinsed and fixed for 1 minute in Amfix. Alternatively, in the case of later 
blots (2007), blots were visualised using the Chemi Hi sensitivity mode on the
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BioRad Gel Doc system using Quantity One software version 4.6.3 (BioRad, 
California, USA).
2.6 Assay of Growth Hormone release from transfected PC12 cells
Freshly trypsinized PC 12 cells were plated out onto pre-coated poly-D lysine 24 
well plates (VWR International, UK) at a density o f-350,000 cells/well 16-24 hours 
prior to transfection. Cells were then transfected using lOOpl transfection reaction 
mixture consisting of lpg control/test plasmid DNA, lpg human Growth hormone 
plasmid (PXGH5) (Nichols Institute Diagnostics, California, USA), 3pl 
LipofectAMINE 2000 transfection reagent (Invitrogen, UK) per pg of plasmid 
DNA, made up to lOOpl in opti-mem (Gibco, Paisley, UK). The transfection 
mixture was incubated at room temperature for 30 minutes before being added drop 
wise to the cells. The cells were then incubated for 4-6 hours at 37°C with the 
transfection reaction mixture before removing the transfection reaction mixture and 
replacing with growth media supplemented with lOpM CdCh. Cells were then 
maintained at 37°C, 5% CO2 for 48 hours before use in experiments.
The secretion assay was performed on either permeabilised or intact cells depending 
upon the experiment. In the case of the former, cells were washed once with KGEP 
buffer (20mM PIPES (pH 6.5), 139mM Kglutamate, 5mM EGTA) before 
permeabilisation with KGEP buffer containing 20pM digitonin (20mM PIPES (pH 
6.5), 139mM Kglutamate, 5mM EGTA, 20pM digitonin) for 6 minutes. Cells were 
then stimulated with 300pl of either 0 or lOpM free Ca2+KGEP buffer for 15 
minutes. For experiments on intact cells, cells were washed with Krebs Ringer 
buffer (20mM HEPES (pH7.4), 145mM NaCl, lOmM glucose, 5mM KC1, 3mM
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CaCl2,1.3mM MgCh, 1.2mM NaH2P0 4 ) and then stimulated for 15 minutes with 
300pl of either 0 or 300pM ATP containing Krebs buffer.
After stimulation, supernatants were collected and stored (these samples contain 
secreted growth hormone) before lysis of the remaining adherent cells in distilled 
water containing 0.5% (v/v) Triton X-100 (300pl/well for 15 minutes, room 
temperature) to give corresponding samples containing unsecreted growth hormone 
to allow calculation of total cellular growth hormone levels.
Released growth hormone was assayed according to the instructions in the hGH 
ELISA kit (Roche Diagnostics, Mannheim, Germany). Final absorbance values 
were read at a wavelength of 405nm, with a reference wavelength of 490nm. The 
amount of secreted growth hormone was calculated and expressed as a percentage of 
total cellular growth hormone for each well. This procedure followed a well- 
established protocol (McFerran et a l, 1998).
61
2.7 Imaging of intracellular [Ca2+] in PC12 cells
PC12 cells (350,000 cells per well) were plated onto collagen coated glass coverslips 
and transiently transfected with 2pg of either ECFP-N1 control plasmid or 2pg of 
KChIPl-ECFP, KChIP2-ECFP, KChIP3-ECFP, KChIP4-ECFP, NCS1-ECFP or 
PS1-EGFP using LipofectAMINE 2000 reagent (Invitrogen) according to the 
manufacturer’s protocol. 48 hours post transfection, cells were washed in Krebs 
buffer (20mM HEPES (pH7.4), 145mM NaCl, lOmM glucose, 5mM KC1, 3mM 
CaCh, 1.3mM MgCl2,1.2mM NaF^PC^) and then incubated with lpM X-rhod-1 
AM (Molecular Probes Europe BV, Leiden, The Netherlands) in Krebs buffer for 30 
minutes at room temperature. Cells were washed in Krebs buffer before imaging 
using laser-scanning confocal microscopy. An ECFP image was taken prior to each 
experiment to allow distinction between transfected and untransfected cells. X- 
rhod-1 was imaged using the Leica microscope with excitation at 543nm and light 
collection at 600-650nm. The X-rhod-1 fluorescence was diffusely and uniformly 
distributed, suggesting cytosolic localization of the probe. Through the application 
of 300pM ATP as an agonist, the effects of the overexpression of the 
aforementioned constructs on ATP-evoked intracellular Ca2+ transients in PC 12 cells 
were then studied by examining the changes in fluorescence of X-rhod-1. This 
approach followed previously published methodology (Haynes et al., 2004).
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2.8 Statistical Analysis
Data in Chapter 4 are generally presented as mean ± SEM of n determinations. A 
student’s two-tailed t test was performed for impaired groups, whereas a one-way 
analysis of variance (ANOVA) was performed for three or more groups. Statistical 
significance was accepted at the p<0.05 level.
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CHAPTER 3:
Analysis of the potential for KChIPs 
to carry out multiple functions 
within the cell
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3.1 Introduction
Of the NCS proteins, the KChIP class has become the most diversified through 
evolution from one KChIP in D.melanogaster to the four KChIP genes and large 
number of potential splice variants that are present in mammals (Pruunsild & 
Timmusk, 2005). At least 16 KChIP isoforms have been detectably expressed in 
human tissue, although some of these KChIP2 isoforms are only expressed in the 
heart (Patel et al., 2002) where KChIP2 plays a role in Kv4 channel regulation (Kuo 
et al., 2001).
A key question regarding the KChIPs is the extent to which they carry out similar 
functions and to what extent their roles differ -  do the individual KChIPs carry out 
specific individual roles, or do they perform similar roles in different cells? There 
are several reasons to believe either scenario. They are certainly expressed in 
different sub-populations of neurons within the brain, as demonstrated through the 
use of PCR after reverse transcription of RNA (RT-PCR) and in situ hybridization 
(Pruunsild & Timmusk, 2005). Furthermore, the C-terminal EF hand-containing 
domains of the human isoforms are at least 70% identical to each other with the 
main difference between the KChEP isoforms lying in the N-terminal domains 
(Burgoyne, 2007). So does this mean that as similar proteins they are simply 
carrying out the same functions but in different neuronal populations? Or does the 
fact that different KChIPs and different isoforms are expressed in varying regions of 
the brain mean that they are carrying out differing functions?
65
With respect to the KChIPs performing similar functional roles, previous work has 
demonstrated that the four different KChIPs do indeed have the ability to carry out 
the same function within the cell -  KChIPs 1-4 all have the ability to regulate Kv4 K+ 
channels (An et al., 2000; Morohashi et al., 2002), and all four reportedly share the 
DRE binding property allowing them to repress transcription (Link et al., 2004). By 
contrast, they have also been reported to have functions that may be distinct to each 
particular KChIP -  KChIP3 for example has been implicated in APP processing 
(Buxbaum et al., 1998), and has been shown to be pro-apoptotic (Jo et al., 2001). 
KChIPs 3 and 4 have been reported to be involved in presenilin processing 
(Buxbaum, 2004), whilst KChIPs 1 and 2 have been shown to have an effect on 
Kvl.5 channel regulation (Li et al., 2005). Not all four KChIPs have been tested in 
these assays however. This area is further complicated by the fact that certain 
functions may be modulated differently by different splice variants from the same 
gene -  for example whilst KChIP4.1 is reported to stimulate traffic of the Kv4 
channel to the plasma membrane (Morohashi et al., 2002), by contrast KChIP4.4 
does not stimulate traffic and leads to almost complete abolition of the fast 
inactivation of Kv4 currents (Holmqvist et al., 2002).
The argument for distinct functions would appear to be given weight by the fact that 
the knock-out mice that have been studied for KChIPs 2 and 3 have observable 
phenotypes indicating that the KChIPs can not compensate for one another (Kuo et 
al., 2001; Cheng et al., 2002; Lilliehook et al., 2003). In addition, while the multiple
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KChIP isoforms have a common EF-hand containing domain, they also possess 
distinct N-termini suggesting the possibility of distinct interactions and functions. 
Here I set out to investigate the four individual KChIPs and their involvement in two 
of their most studied functional roles, namely the regulation of the traffic of Kv K+ 
channels and their interaction with the presenilins. I investigated the intrinsic 
targeting of GFP-variant tagged isoforms of human KChIPs 1-4, when expressed 
alone or together with GFP-variant tagged constructs of human Kvl .4, human 
Kvl .5, human Kv4.2 or human presenilin-1, and these observations provided some 
answers as to whether or not the KChIPs share these functions. Furthermore, I also 
investigated another NCS protein, NCS-1, which has been suggested to have similar 
effects to KChIPs with respect to certain functions, and is also known to carry out 
multiple distinct cellular roles.
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3.2 Results
3.2.1 The KChIPs localise to different regions of the cell
In order to study the multiple functions of the KChIPs, I first set out to investigate 
their individual cellular localisations by using GFP-variant tagged KChIP constructs 
expressed in COS-7 cells and subsequently visualising them under the confocal 
microscope. This initially involved tagging the C-terminus of KChIPs 2-4 with 
ECFP and using an existing, similarly tagged KChIP 1 construct (Figure 10), then 
confirming that these proteins were expressed by the cells, once transfected, by 
Western Blotting analysis (Figure 11). Bands for the fusion proteins were detected 
at the expected size of ~52kDa for KChIP 1-ECFP and ~57kDa for the other ECFP 
tagged KChIPs, using both an anti-GFP antibody and an anti-pan KChIP antibody. 
The KChIPs were tagged at the C-terminus so as to minimise potential interference 
with post-translational modifications that might be important for their intrinsic 
targeting and localisation. KChIP 1.2 is myristoylated, whilst KChIPs 2.1, 2.2, 2.3,
3.1 and 4.1 all possess potential palmitoylation sites (Burgoyne, 2007), with these 
post-translational modifications thought to be relevant for their intracellular 
targeting and some functional activity. Palmitoylation of KChIPs 2.3 and 3.1 is 
necessary for the efficient trafficking of Kv4 channels for example (Takimoto et al., 
2002).
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At this point the diverse nature of the KChIP class should be noted. Analysis in 
human tissue has indicated that at least 16 KChIP isoforms are detectably expressed, 
with the major difference between these splice variants lying at the N-terminus. As 
current literature on these splice variants has given different variants multiple names 
(Decher et al., 2004; Jemg et al., 2004), I will use the terminology shown in figure 
12 (Burgoyne, 2007), with the work carried out in this study using KChIPs 1.2, 2.3,
3.1 and 4.1. When I refer to KChIPsl-4, this corresponds to the aforementioned 
splice variants.
COS-7 cells were used in contrast to previous localisation studies in this laboratory 
using HeLa cells, as KChIP3 has been shown to induce significant levels of 
apoptosis when overexpressed in HeLa cells (Jo et al., 2001). Initial experiments 
confirmed this finding (data not shown). COS-7 cells have been used by several 
other groups studying KChIP3, and are a widely used research tool as they grow 
adherently to both glass and plastic in a monolayer, enabling their ease of use for 
imaging experiments. COS-7 cells were developed from an African green monkey 
kidney fibroblast cell line, and exhibit typical fibroblast morphology. When 
expressed in COS-7 cells, the four KChIPs show different localisation patterns 
which may be relevant to their functional roles, particularly that of stimulating 
traffic of Kv4 channels to the plasma membrane (figure 13). KChIP 1.2 was present 
on vesicular structures, with this localisation previously having been shown to be 
dependent upon its myristoylation (O'Callaghan et al., 2003a). It has been shown 
that this targeting to intracellular vesicles enables an increase of efficiency of
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trafficking Kv4 channels to the plasma membrane (Hasdemir et al., 2005).
KChIP2.3 was expressed on the plasma membrane, due to its palmitoylation -  
previous work has shown that only palmitoylated KChIP2 associates with the 
plasma membrane (Shibata et al., 2003; Burgoyne, 2007). It is therefore surprising 
that both KChIPs 3.1 and 4.1 differ from KChIP2.3 in their localisation. Both also 
possess a palmitoylation site, yet KChIPs 3.1 and 4.1 remained diffuse and present 
in the cytosol and nucleus when expressed alone.
To examine whether the findings made in COS-7 cells were specific to this cell type, 
the localisations of the various fusion proteins were also investigated in PC 12 cells 
as well. PC 12 cells are widely used as a neuronal and neuroendocrine cell model 
and are known to possess many proteins that are believed to be neuronal specific.
PC 12 cells are tumour cell derivatives of adrenal chromaffin cells, which are derived 
embryonically from the neural crest like sympathetic neurons. Although they have 
been shown to express endogenous NCS-1 (McFerran et al., 1998), which is 
localised to the TGN and plasma membrane, it is not known whether PC12 cells 
express any of the KChIP splice variants endogenously. However, when transiently 
transfected, KChIP 1.2 was targeted to punctate structures, KChIP2.3 was localised 
to the plasma membrane and KChIPs 3.1 and 4.1 were diffuse and cytosolic, similar 
to transiently transfected COS-7 cells (figure 14). Again, expression was confirmed 
by Western blot analysis and bands for the fusion proteins were detected at the 
expected size of ~52kDa for KChIP 1-ECFP and ~57kDa for the other ECFP tagged 
KChIPs, using both an anti-GFP antibody and an anti-pan KChIP antibody (figure
70
11C). The pan-KChIP antibody did not appear to pick up any endogenous KChIPs 
in untransfected cells, though given its inefficiency in detecting KChIP3,1 could not 
determine if PC 12 cells express KChIP3 endogenously. It appears that the situation 
in transfected COS-7 cells appears to be representative of that in more physiological 
cell types, such as PC 12 cells, where the fusion proteins localised in a similar way.
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Figure 10. Agarose gels showing plasmids prepared for the project.
(A) FLAG-tagged KChIP constructs. In each case plasmids were digested with 
the restriction enzymes used to clone in the desired insert (n=3). (B) ECFP-tagged 
KChIP constructs. In each case plasmids were again digested with the appropriate 
restriction enzymes (n=3). EGFP-tagged presenilin-1 is also shown for comparison. 
In this case the presenilin insert contains an EGFP tag in the cytoplasmic loop 
giving a larger insert of 2.7kb.
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5 0 ^- l l s t l l  anti-pan KChIP
Figure 11. Western blots to show expression of fluorescent-tagged proteins in 
COS-7 and PC12 cells.
(A) Expression of ECFP-tagged KChIPs and EGFP-tagged presenilin-1 in COS-7 
cells, detected by Western blotting using an anti-GFP antibody (1:5000). Bands for 
presenilin-1 are detected at both the expected molecular weight and at a higher weight, 
indicating an aggregation of the protein (n=2). (B) Detection of ECFP-tagged 
KChIPs using an anti-GFP antibody (1:5000) and an anti-pan-KChIP antibody 
(1:1000). The pan-KChIP works well for KChIPs 1, 2 and 4, but is not efficient at 
detecting KCMP3. The upper panel shows an anti-GFP blot for ECFP tagged versions 
of the proteins, the lower shows an anti-pan-KChIP blot from a gel run using identical 
amounts of the same cell lysates from COS-7 cells (n=3). (C) Detection of expression 
of ECFP-tagged KChIPs by Western blotting using anti-GFP and anti-pan-KChIP 
antibodies using cell lysates from transfected PC 12 cells (n=3).
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Figure 12. The KChIP class of NCS proteins and their splice variants (adapted 
from Burgoyne 2007).
The alternative splicing of the four human KChIP genes generates a series of 
splice variants with distinct amino (N)-terminal domains. Some of the isoforms 
possess myristoylation or palmitoylation sites (as indicated) that could confer 
membrane targeting and localisation. There is no generally agreed terminology for 
KChIP isoforms, and those shown are based on =the following sequences: human 
KChIPl isoforms: GenBank accession number DQ148478 (1.1), DQ148477 (1.2), 
DQ148476 (1.3). Human KChIP2isoforms: NM_01491 (2.1), DQ148480 (2.2), 
DQ 148481 (2.3), DQ148482 (2.4), DQ148483 (2.5). Human KChIP3 isoforms 
DQ148485 (3.1), DQ148486 (3.2). Human KChIP4 isoforms:DQ148487 (4.1), 
DQ148488 (4.2), DQ148491 (4.3), DQ148489 (4.4), DQ148490 (4.5),
DQ 148492 (4.6).
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Figure 13. Differential localisation of four KChIPs when expressed in COS-7 
cells.
COS-7 cells were transfected to express ECFP-tagged KChIPs from each of the 
four KChIP genes and then cells were imaged live on the confocal microscope 2 
days post-transfection. KChIP 1.2 localises to distinct punctate vesicles within the 
cell, whilst KChIP2.3 is found predominantly on the plasma membrane. KChIPs 3.1 
and 4.1 appear to be mainly cytosolic, though were also present in the nucleus. In 
each case the scale bar represents 10 pm.
75
Figure 14. Differential localisation of four KChIPs when expressed in PC12 
cells.
PC 12 cells were transfected to express ECFP-tagged KChIPs from each of the four 
KChIP genes and then cells were imaged live on the confocal microscope 2 days 
post-transfection. In a similar manner to COS-7 cells, KChIP 1.2 localises to distinct 
punctate vesicles within the cell, whilst KChIP2.3 is found predominantly on the 
plasma membrane. KChIPs 3.1 and 4.1 appear to be mainly cytosolic, though were 
also present in the nucleus. Images are representative of 82% (23/28) of 
KChIP1.2 transfected cells, 89% (17/19) KChIP2.3 transfected cells, 96% (26/27) 
of KCMP3.1 transfected cells and 92% (23/25) of KChIP4.1 transfected cells.
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3.2.2 The KChIPs do not possess a Ca2+/myristoyl switch mechanism
The first of the NCS proteins to be characterised at a structural level, recoverin, 
possesses a reversible Ca /myristoyl switch mechanism, where Ca -binding leads 
to exposure of the myristoyl group and subsequent membrane association (Ames et 
al., 1997). This Ca /myristoyl switch is present in other NCS proteins, but not all. 
For example, hippocalcin, neurocalcin 5, VILIP-1 and VILIP-3 have all been shown 
to possess a Ca /myristoyl switch and will translocate to the plasma membrane and 
TGN upon an increase in cytosolic Ca2+ concentration (Spilker et al., 2002a; 
O'Callaghan et al., 2003b; Spilker & Braunewell, 2003). By contrast, NCS-1 has its 
myristoyl group constitutively exposed, even in the absence of Ca2+, meaning that it 
is already associated with the plasma membrane and the TGN at resting or lowered 
Ca2+ levels (Ames et al., 2000; Bourne et al., 2001; Burgoyne et al., 2004; 
O'Callaghan & Burgoyne, 2004).
Here I confirm previous work from this laboratory demonstrating that KChIPl, 
despite being myristoylated, does not possess a Ca2+/myristoyl switch mechanism 
but is constitutively membrane associated (O'Callaghan & Burgoyne, 2003; 
O'Callaghan et al., 2003a), and confirm that KChIPs2, 3 and 4, whilst not 
myristoylated, do not possess a switch mechanism or display any translocation to 
specific cellular compartments upon cytosolic Ca2+ elevation.
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In order to check for Ca2+ -dependent changes in localisation, COS-7 cells were co­
transfected to express a KChIP-ECFP construct together with a positive control, 
hippocalcin-EYFP, as this is known to show a Ca2+/myristoyl switch mechanism. 
When treated with the Ca ionophore ionomycin, there was no change in the 
distribution of KChIPl-ECFP over time following Ca2+ elevation in living COS-7 
cells. By contrast, the co-transfected hippocalcin-EYFP translocated from the 
cytosol to membranes most likely the plasma membrane and the Golgi complex as 
previously reported (figure 15). Similarly, KChIPs2, 3 and 4 remained in their 
particular cellular localisations upon Ca elevation -  KChIP2 was located to the 
plasma membrane whilst KChIPs 3 and 4 remained cytosolic. Again, the co­
transfected hippocalcin-EYFP translocated as expected from the cytosol to the 
plasma membrane and the Golgi complex in response to Ca2+ elevation (figures 16- 
18).
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Figure 15. Localisation of KChIPl and hippocalcin and the effects of Ca2+ 
elevation with the Ca2+ionophore ionomycin.
COS-7 cells were transfected to co-express hippocalcin-EYFP together with 
KChIPl-ECFP. Cells were then imaged live via confocal microscopy 2 days 
post-transfection. Hippocalcin is cytosolic under resting conditions (0 min), but 
following treatment with 5pM ionomycin, the subsequent Ca2+ elevation causes 
translocation due to its Ca2+/myristoyl switch. By contrast, the KChIPl does not 
display a similar translocation following Ca2+ elevation. KChIPl has its myristoyl 
group exposed regardless of Ca2+binding status (i.e. no switch) and is found associated 
on vesicles within the cell.
79
Figure 16. Localisation of KChIP2 and hippocalcin and the effects of Ca2+ 
elevation with the Ca2+ionophore ionomycin.
COS-7 cells were transfected to co-express hippocalcin-EYFP together with 
KChIP2-ECFP. Cells were then imaged live via confocal microscopy 2 days post­
transfection. Hippocalcin is cytosolic under resting conditions (0 min), but following 
treatment with 5pM ionomycin, the subsequent Ca2+ elevation causes translocation 
due to its Ca27myristoyl switch (lower traces). KChIP2 however remains constitutively 
associated to the plasma membrane (upper traces).
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Figure 17. Localisation of KChIP3 and hippocalcin and the effects of Ca2+ 
elevation with the Ca2+ionophore ionomycin.
COS-7 cells were transfected to co-express hippocalcin-EYFP together with 
KChIP3-ECFP. Cells were then imaged live via confocal microscopy 2 days post­
transfection. Hippocalcin is cytosolic under resting conditions (0 min), but following 
treatment with 5pM ionomycin, the subsequent Ca2+ elevation causes translocation 
due to its Ca27myristoyl switch. By contrast, the KChIP3 does not display a similar 
translocation following Ca2+ elevation and remains cytosolic (upper traces).
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Figure 18. Localisation of KChIP4 and hippocalcin and the effects of Ca2+ 
elevation with the Ca2+ionophore ionomycin.
COS-7 cells were transfected to co-express hippocalcin-EYFP together with 
KChIP4-ECFP. Cells were then imaged live via confocal microscopy 2 days post­
transfection. Hippocalcin is cytosolic under resting conditions (0 min), but following 
treatment with 5pM ionomycin, the subsequent Ca2+ elevation causes translocation 
due to its Ca27myristoyl switch (lower traces). KChIP4 however remains cytosolic 
(upper traces).
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3.2.3 The KChIPs and their interaction with the Kv channels
3.2.3.1 The Kv channels localise to different regions of the cell
Having shown the differential localisation of the four KChIPs, I then set out to 
investigate differences in their functions. Perhaps the most widely studied function 
of the KChIPs is their interaction with the Kv potassium channels, and specifically 
their effects on the stimulation or inhibition of the traffic of these channels to the 
plasma membrane. In order to investigate this further, I utilised three existing GFP- 
variant tagged channels of the Kv family (Kvl.4, Kvl.5 and Kv4.2) that had 
previously been studied with one or more of the KChIPs (O'Callaghan et a l, 2003a; 
Hasdemir et a l, 2005; Li et a l, 2005). Interestingly, each of the three channels 
showed distinct intracellular localisation when expressed alone (figure 19).
When expressed in the absence of any of the KChIPs in COS-7 cells and visualised 
under the confocal microscope, the three channels all exhibited differing 
localisation. Kvl.4-EGFP was very clearly plasma membrane associated, whilst 
ECFP-Kv4.2 was found to localise to the perinuclear region of the cell (figure 19). 
Both of these findings were as expected on the basis of previous studies 
(O'Callaghan et a l, 2003a; Hasdemir et a l, 2005; Li et a l, 2005). Kvl .5-EGFP was 
found to display a reticular staining pattern, with little or no expression of GFP 
present on the cell surface. This is in contrast to the findings of H.Li et al (2005) 
who showed that when expressed in HEK-293 cells, whilst the majority of the
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channel appeared to remain in the ER, there was some expression of GFP evident at 
the cell surface, which in some cases appeared to be aggregated. This may be a cell- 
type specific phenomenon, but it is important in the context of some of the 
experiments to follow, as KChIP2 was suggested to prevent the forward traffic of 
Kvl .5-encoded channels, resulting in Kvl .5 retention in the ER (Li et al., 2005). 
However, in the case of COS-7 cells at least, the vast majority of the channel would 
already seem to be retained.
Kvl .4-EGFP
¡§
■i
■ ECFP-Kv4.2
Figure 19. Localisation of Kvl.4-EGFP, Kvl.5-EGFP and ECFP-Kv4.2.
COS-7 cells were transfected with either Kvl.4-EGFP, Kvl.5-EGFP or ECFP-Kv4.2 
and imaged live on the confocal microscope 48 hours post-transfection. Whilst 
Kvl.4-EGFP is found to be predominantly membrane associated on the plasma 
membrane, Kvl.5-EGFP displays a reticular localisation, with very occasional 
patches of plasma membrane expression. ECFP-Kv4.2 localises to the perinuclear 
region, previously identified as the Golgi apparatus.
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3.23.2 ECFP and EGFP-labelled proteins can be co-expressed and are 
individually identifiable
Before co-expressing the KChIPs and the Kv channels, as all of the KChIPs were 
ECFP-tagged and two of the channels had were EGFP-tagged, it was important to 
confirm that such tagged proteins could be individually distinguished, as the 
excitation and emission wavelengths for ECFP and EGFP overlap to a certain extent 
(figure 20A, B).
To check that it was possible to co-express ECFP and EGFP-tagged proteins 
together, and identify each individually, I used two tagged proteins known to 
localise to different regions of the cell but not known to interact with each other, 
namely KChIP3-ECFP and another existing construct, a temperature sensitive 
mutant of the vesicular stomatitis virus G protein (ts045 VSVG-EGFP). For the 
purposes of this experiment, the temperature sensitive aspect was not important. 
Briefly however, at a restrictive temperature of 40°C, ts045 VSVG-EGFP has a 
thermo-reversible folding defect which retains it in the ER, whilst at a permissive 
temperature of 32°C, synchronous folding of the protein is enabled which allows the 
protein to exit from the ER and traffic to the Golgi apparatus and further to the 
plasma membrane (Bergmann, 1989; Hirschberg et al., 1998). At 37°C, the 
temperature used for this experiment, ts045 VSVG-EGFP could be found localised 
to the Golgi apparatus and the plasma membrane, whilst KChIP3-ECFP was 
cytosolic (figure 13).
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When the proteins were co-expressed in COS-7 cells, with each individual protein 
excited and light collected at appropriate wavelengths, both proteins were readily 
identifiable in their distinct cellular localisations (figure 20C). The fact that both 
proteins were distinctly localised showed that ECFP and EGFP-tagged proteins were 
suitable for their use in co-expression studies.
Emission
Figure 20. ECFP and EGFP labelled proteins can be co-expressed in cells and 
are individually identifiable.
ECFP and EGFP labelled constructs have excitation and emission spectra that share 
some degree of overlap (A, B). In order to check that it is possible to co-transfect 
cells with ECFP and EGFP labelled proteins then identify each separately, COS-7 
cells were co-transfected with KChIP3-ECFP, a mainly cytosolic protein, and 
VSVG-EGFP, a protein that is membrane associated to the plasma membrane and 
Golgi complex. Cells were fixed 48 hours post-transfection and imaged on the 
confocal microscope (C). Distinct localisations of the two tagged proteins were 
readily resolved. The colour overlay shows KChIP3-ECFP in red and VSVG-EGFP in 
green.
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Having demonstrated both the individual cellular localisations of the KChIPs and the 
Kv K+ channels respectively, it was next examined whether co-expressing each 
different KChIP with each Kv K+ channel would affect the localisation of either 
protein.
When expressed alone, Kvl .4-EGFP was found to be associated with the plasma 
membrane, with a small amount retained intracellularly (figure 19), and indeed, 
when co-expressed with the KChIP 1-ECFP the channel can still be seen to have 
reached the plasma membrane with the KChIP retaining its individual cellular 
localisation (figure 21 A). Similarly, when the channel was co-expressed with 
ECFP-tagged KChIPs 3 and 4, the GFP expression was clearly evident on the cell 
surface, suggesting that forward traffic of the channel to the plasma membrane had 
occurred, with both of the KChIPs retaining their cytosolic localisation. However, 
whilst forward traffic of the channel was still evident in these cases, it was also 
possible to observe some GFP-fluorescence in perinuclear regions of the cell, 
suggesting some retention of the channel (figure 21C, D).
When KChIP2-ECFP was co-transfected with Kvl.4-EGFP, it retained its 
association with the plasma membrane, as seen by the CFP fluorescence at the cell 
surface (figure 2 IB). By contrast, the channel itself was no longer seen to be
3.2.3.3 KChIP2 inhibits the traffic of the Kvl.4 channel to the plasma
membrane in COS-7 cells
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trafficked to the plasma membrane but was instead retained intracellularly, with 
hardly any GFP-fluorescence seen at the plasma membrane. The fluorescence seen 
exhibited a reticular pattern, suggesting Kvl .4 retention in the ER and in turn 
suggesting that co-expression of KChIP2 had prevented the forward trafficking of 
Kvl .4-encoded channels. Previous work by Li et al (2005) has shown that KChIP2 
co-expression can reduce the cell surface expression of Kvl .5, and from these results 
it would appear that KChIP2 can play a similar inhibitory role in the forward traffic 
of Kvl .4.
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Figure 21. KChIP2 inhibits traffic of the Kvl.4 channel to the plasma membrane 
in COS-7 cells.
Cells were transfected to co-express KChIPsl-4 (as indicated A-D) together with 
Kvl.4-EGFP. In the case of KChIPs 1,3 and 4, the channel is still clearly localised to 
the plasma membrane (A, C, D). However in the case of cells co-transfected with the 
channel and KChIP2-ECFP (B), the traffic of the channel appears to be inhibited and 
the Kvl.4 remains trapped in the ER/Golgi region. The colour overlays show the 
KChIPs in red, Kvl.4 in green and areas of co-localisation in yellow.
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Previous studies have demonstrated that KChIP2 (and KChIPl) can modulate the 
functional cell surface expression of Kvl.5-encoded K+ channels in transiently 
transfected HEK-293 cells, where both KChIPl and 2 can reduce current densities 
and cell surface expression of Kvl .5. It is thought that this reduction in cell surface 
expression of Kvl.5 is due to the KChIPs inhibiting forward traffic of the channel 
from the endoplasmic reticulum (Li et al., 2005).
In order to investigate this further, I co-expressed a GFP-variant tagged Kvl .5 
(Kvl .5-EGFP) with each of the four CFP-tagged KChIPs in COS-7 cells and 
analysed changes in cellular localisation by utilising confocal microscopy. It is 
important to note at this point however, that in COS-7 cells at least, it was very 
difficult to visualise any Kvl.5-EGFP fluorescence at the plasma membrane (figure 
19) with the vast majority of the protein retained intracellularly in the ER/Golgi 
region. Thus it was difficult to consider any inhibitory effects that the KChIPs may 
possess.
When KChIPs 1, 3 and 4 are co-expressed with Kvl.5-EGFP, neither the 
localisation of the KChIPs or the channel displayed any significant change, and the 
proteins did not appear to co-localise to any great extent (figure 22A, C, D). When 
co-expressed with KChIP2, the channel again maintained an intracellular
3 .2 3 .4  The KChIPs do not appear to affect the traffic of the Kvl.5 channel in
COS-7 cells
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localisation, and although a larger proportion of KChIP2 appeared to be retained 
within the cell in the perinuclear region, it was still clearly visible on the plasma 
membrane and did not exhibit complete co-localisation with the Kv 1.5 channel 
(figure 22B). Therefore it is difficult to conclude any effect on trafficking of the 
Kvl.5 channel, other than the KChIPs do not stimulate traffic of the channel to the 
plasma membrane. They may play an inhibitory role but this is difficult to conclude 
from my data, and it may be that effects seen are isoform or cell type specific.
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Figure 22. Co-expression of fluorescent KChIPs and Kvl.5-EGFP in COS-7 
cells does not stimulate traffic of Kvl.5 to the plasma membrane.
COS-7 cells were transfected to co-express Kvl.5-EGFP and one of KChIPs 1(A), 
2(B), 3(C) or 4(D) as indicated and imaged 48 hours post-transfection. In each case, 
the KChIP does not stimulate traffic of the channel to the plasma membrane, and the 
proteins do not co-localise to any extent, with the channel remaining in a perinuclear 
region of the cell and the KChIPs retaining their distinct cellular localisations. The 
colour overlay shows the KChIPs in red and the channel in green, with regions of 
overlap in yellow.
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3.2.3.5 The KChIPs can stimulate traffic of the Kv4.2 channel to the plasma 
membrane
One of the most studied of the KChIP’s functions is that of their interaction with the 
Kv4 channels. The first study of the effects of the KChIPs on Kv4 channels 
compared KChIPs 1.2, 2.3 and 3.1, which were all found to have the same effects 
(albeit with some quantitative differences): increasing cell surface expression of 
Kv4, shifting the voltage-dependency of activation, slowing inactivation and more 
rapidly recovering from inactivation (An et al., 2000). Later studies on a KChIP4 
isoform, KChIP4.1, showed similar effects in increasing traffic to the cell surface 
and slowing channel inactivation (Holmqvist et a l, 2002; Morohashi et a l, 2002).
I set out to confirm that these KChIP isoforms all promote traffic of Kv4.2 channels 
to the plasma membrane, again by using GFP-variant tagged KChIP constructs and a 
pcDNA-Kv4.2 construct. Here, the mention of KChIP isoforms is particularly 
relevant as some isoforms of KChIPs 2 and 4 have been shown to have differing 
effects -  one KChIP2 isoform actually inhibits Kv4 surface expression (Patel et a l, 
2002; Decher et a l, 2004), whilst the KChIP4.4 isoform does not stimulate traffic of 
the Kv4 channels and leads to the almost complete abolition of the fast inactivation 
of Kv4 channels (Holmqvist et a l, 2002; Morohashi et a l, 2002).
When expressed alone in cells, Kv4.2 can be found to be concentrated within a 
perinuclear region of the cell, previously identified as the Golgi (O'Callaghan et al,
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2003a) (figure 19). However, when the Kv4.2 channel was co-expressed in COS-7 
cells with each of the KChIPs, with subsequent immunostaining against Kv4.2, the 
distribution of both the KChIPs and the channel within the cell was altered (figure 
23A-D). In every case, ECFP fluorescence was detected at the plasma membrane, 
demonstrating a change in localisation of the KChIPs. This fluorescence almost 
perfectly co-localised with the immunostaining against the Kv4.2, which was now 
found at the cell surface. These findings confirm that the four KChIP splice variants 
tested can all stimulate forward traffic of the Kv4.2 channel to the plasma 
membrane.
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Figure 23. Co-expression of fluorescent KChIPs and Kv4.2-pcDNA in COS-7 
cells stimulates traffic of Kv4.2 to the plasma membrane.
COS-7 cells were transfected to co-express Kv4.2 and one of KChIPs 1(A),
2(B), 3(C) or 4(D) as indicated and imaged 48 hours post-transfection. The cells 
were fixed and immunostained with anti-Kv4.2 antibody, using a Dylight secondary 
to detect the expressed channel. In each case, the KChIP clearly stimulates traffic 
of the channel to the plasma membrane, with the two proteins co-localising at this 
region of the cell. The colour overlays show the KChIPs in green and Kv4.2 in red, 
with co-localisation seen in yellow.
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3.2.4 The KChIPs and their interaction with the presenilins
3.2.4.1 Presenilin-l-EGFP can be expressed in both COS-7 and PC12 cells and 
is localised to the endoplasmic reticulum (ER)
KChIP3 was first identified as a Ca2+ binding protein that binds to the last 103 
amino acids of presenilins 1 and 2, and as such was originally named calsenilin 
(Buxbaum et al., 1998). This generated significant interest as the presenilins and 
more specifically, mutations in the genes encoding them, are known to be involved 
in early onset familial Alzheimer’s disease (FAD) (Tandon & Fraser, 2002). 
Subsequent work also indicated a similar interaction between the presenilins and 
KChEP4 (Morohashi et al., 2002).
To examine whether this interaction is specific to particular KChIPs, I used the 
ECFP-tagged KChIPs in conjunction with an existing presenilin-1 construct (PS1- 
EGFP) that contained an EGFP tag in its cytoplasmic loop (Kaether et al., 2002), 
and co-expressed these proteins within COS-7 cells to examine their intracellular 
localisations and potential interactions.
Firstly, it was important to confirm the intracellular localisation of PS 1-EGFP when 
expressed alone in cells, as previous studies have provided contrasting results. 
Several groups described the presenilins as being predominantly located within early 
compartments such as the ER and the intermediate compartment (Annaert et al.,
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1999; Cupers et al., 2001), whilst others found them to be localised to post-Golgi 
compartments (Takashima et al., 1996; Efthimiopoulos et al., 1998; Ray et al., 1999; 
Schwarzman et al., 1999; Singh et al., 2001). Furthermore, one study demonstrated 
the ability of the presenilins to reach the cell surface, though most of the protein is 
retained within the cell (Kaether et a l, 2002). Here I found that when PS1-EGFP is 
transiently transfected into both COS-7 and PC 12 cells, it demonstrated a reticular 
localisation (figure 24A, B) with no obvious plasma membrane association visible.
To confirm expression, Western blot analysis was used in conjunction with an anti- 
PS 1 antibody. These results were complicated by the fact that a high molecular 
weight aggregate of the protein can be detected (figure 24C). But, when cell lysates 
are left unboiled, a band corresponding to the filli length protein together with the 
fused EGFP tag can be detected. Whether the high molecular weight band found 
represents an accumulation of proteolytic fragments, or indeed of the full length 
protein, is unknown. However, previous work has indicated that the insertion of the 
EGFP tag does not affect the physiological function of the protein (Kaether et al., 
2002) .
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Figure 24. Expression of GFP-tagged presenilin-1 in COS-7 and PC12 cells.
COS-7 cells were transfected with PS1-EGFP and imaged 48 hours post-transfection. 
Presenilin-1 displays a reticular localisation (A). Similarly, in transfected PC 12 cells, 
presenilin-1 shows a reticular localisation (B). When Western blotting for the protein, 
the protein forms a high molecular weight aggregate (C). However, if cell lysates are 
left unboiled, a clear band corresponding to the correct molecular weight of the 
tagged protein can be seen.
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3 .2 A .2  KChIP3-ECFP co-localises with presenilin-l-EGFP when co-expressed 
in COS-7 cells
In this study, I investigated if the KChIPs could stimulate traffic of presenilin-1 to its 
site of action at the plasma membrane, or indeed whether they appear to interact 
with presenilin-1. It has previously been demonstrated that the KChIPs can act to 
stimulate traffic of the Kv4 channels from the Golgi complex to the plasma 
membrane (O'Callaghan et a l, 2003a) and here I studied the possibility that the 
KChIPs could perform a similar function with respect to the trafficking of 
presenilin-1.
KChIPs 2 and 4 did not appear to co-localise with presenilin-1, with each individual 
KChIP maintaining its own cellular localization (figure 25B and D). In the case of 
KChIP4 this was slightly unexpected as some work has suggested a role for KChIP4 
in presenilin processing (Morohashi et a l, 2002). When co-expressed with KChIP 1, 
whilst there was some apparent co-localisation with PS1-EGFP, the ECFP and 
EGFP detected did not form a perfect overlap (figure 25A). However, when 
KChIP3 was co-expressed with PS 1-EGFP, a change in the localization of KChEP3 
was observed, with a large proportion of the ECFP fluorescence detectable in the 
perinuclear region of the cell and overlapping somewhat with the EGFP 
fluorescence from the presenilin construct (figure 25C). This redistribution of 
KChIP3 to the perinuclear region is similar to the effect observed by Buxbaum et al 
(1998), who demonstrated a comparable effect when co-expressing KChIP3 with
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presenilin-2. This data would suggest that KChIP3 can become associated with 
membranes in the presence of presenilin-1. Indeed, it was also possible to observe 
some small regions of co-expression at the plasma membrane. This data is 
consistent with an interaction between KChIP3 and the cytoplasmic domain of 
presenilin-1 that has previously been demonstrated by co-immunoprecipitation 
(Buxbaum et al., 1998).
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Figure 25. KChIP3 co-localises with presenilin-1 when co-expressed in COS-7 
cells.
ECFP-tagged KChIPs 1-4 (A-D as indicated) were transfected along with PS1-EGFP 
into COS-7 cells. KChIPs 2 and 4 do not co-localise with the presenilin, with each 
protein retaining its distinct localisation (B, D). In the case of KChIPl there is some 
co-localisation with presenilin-1, but this is not a perfect overlap, and the localisation 
of the presenilin does not appear to change significantly (A). Cells co-transfected 
with KChIP3-ECFP and PS1-EGFP exhibit a more significant change in localisation 
of the KChIP3-ECFP and it exhibits a more perinuclear localisation and partially 
co-localises with PS1-EGFP (C). The colour overlays show PS1-EGFP in green, 
the KChIPs in red and areas of overlap in yellow.
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3.2.4.3 KChIP3 does not appear to exhibit preferential binding for either 
presenilin-1 or Kv4.2
Having established that KChIP3 can apparently interact with both presenilin-1 and 
the Kv4.2 K+ channel, I set out to try and establish if KChIP3 exhibited a preference 
for binding to either protein, and indeed whether co-expressing all 3 proteins would 
result in a change in their intracellular localisation. Again, in order to study this, 
COS-7 cells were transiently transfected with GFP-variant tagged KChIP3 and 
presenilin-1 constructs, together with Kv4.2, and the intracellular distribution of the 
three proteins then visualised using confocal microscopy.
A large proportion of the each of the expressed proteins remained trapped within the 
cell, with all three proteins appearing to co-localise in the perinuclear region of the 
cell. However, it was also observed that both KChIP3 and Kv4.2 were present on 
the plasma membrane of the cell, suggesting that the overexpression of presenilin-1 
did not block traffic of the channel to the plasma membrane by KChIP3 (figure 26). 
Furthermore, small areas of EGFP fluorescence were visible on the cell surface, 
suggesting that presenilin-1 is also being trafficked to the plasma membrane, though 
the vast majority of the presenilin is retained within the cell.
These data would suggest that KChIP3 is able to interact independently with both 
Kv4.2 and presenilin-1, but does not exhibit preferential binding for either protein. 
Moreover, the presenilin does not prevent traffic of the channel to the plasma
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membrane, nor does the channel appear to prevent presenilin-1 becoming membrane 
associated in the presence of KChIP3.
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Figure 26. Triple transfection of COS-7 cells with KChIP3-ECFP, PS1-EGFP 
andKv4.2-pcDNA.
Cells were transfected with KChIP3-ECFP, PS1-EGFP and Kv4.2 then 
imaged 48 hours post-transfection. The cells were fixed and immunostained with 
anti-Kv4.2 antibody, using a Dylight secondary to detect the expressed channel.
Whilst KChIP3 appears to co-localise with both presenilin-1 and Kv4.2, it does not 
appear to exhibit preferential binding to either protein and all three proteins appear to 
localise to the ER/Golgi region of the cell, with the channel also reaching the plasma 
membrane and PS1 not blocking its traffic. The colour overlay shows areas of overlap 
in white.
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3.2.5 NCS-1 exhibits some properties similar to those of the KChIPs
The KChIPs are not the only NCS proteins that have been reported to modulate Kv4 
channels. NCS-1 has also been reported to regulate Kv4 channels as well (Guo et 
al., 2002; Nakamura et al., 2003), although the discoveries made by previous 
investigations have been somewhat contradictory (Ren et al., 2003; Zhang et a l, 
2003). NCS-1 is known to possess multiple functions (Pongs et al., 1993; McFerran 
et al., 1998; Weiss et al., 2000; Gomez et al., 2001; Zhao et al., 2001; Guo et al., 
2002; Kabbani et al., 2002; Koizumi et al., 2002; Tsujimoto et al., 2002; Sippy et 
al., 2003; Haynes et al., 2005; Burgoyne, 2007), and is highly expressed not only in 
all brain regions but also in many non-neuronal cell types (McFerran et al., 1998; 
Paterlini et al., 2000; Gierke et al., 2004). Here, I set out to investigate whether 
NCS-1 could indeed carry out some of the same functions as the KChIPs, again by 
utilising GFP-variant tagged constructs of NCS-1 (NCS-l-ECFP), the channels 
(Kvl.4-EGFP, Kvl.5-EGFP) and presenilin-1 (PS1-EGFP) as well as an untagged 
Kv4.2 construct (Kv4.2-pcDNA) and studying their co-expression in COS-7 cells 
using confocal microscopy.
To demonstrate correct expression of NCS-l-ECFP, the construct was transiently 
transfected into COS-7 cells and examined using both confocal microscopy and 
Western blot analysis (figure 27A, B). When expressed alone, NCS-l-ECFP can 
clearly be found associated to the Golgi and the plasma membrane as described 
previously (O'Callaghan et al., 2002).
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The results of the co-expression experiments were not clear-cut. As previously 
reported, when co-expressed with Kv4.2, NCS-1 appears to be able to stimulate 
traffic of the channel to the plasma membrane (figure 28A). However, this 
trafficking effect is not always evident in all cells examined (figure 28B). Similarly, 
when co-expressed with Kvl.4, a retention effect similar to that seen with KChIP2 
was observed in some cells (figure 29A) with both NCS-1 and Kvl .4 apparently 
retained within the Golgi region of the cell, though this was not always the case, and 
in some other cells Kvl .4 clearly reached the plasma membrane with no apparent 
disruption in its traffic by NCS-1 (figure 29B). When NCS-1 was co-expressed with 
Kvl.5, in common with the KChIPs, NCS-1 did not demonstrate any affect on the 
traffic of the channel and the proteins did not appear to co-localise within the cell 
(figure 30).
Interestingly, when NCS-1 is co-expressed with presenilin-1, there is also the 
suggestion of an interaction taking place, but, again, the results are not clear cut. 
Some co-transfected cells exhibited both proteins in their expected individual 
cellular localisations, with NCS-1 found to be present on the Golgi and plasma 
membrane, and presenilin-1 in the ER (figure 31 A). However, in other cells a 
change in localisation of presenilin-1 was observed, with presenilin-1 and NCS-1 
now co-localised in a perinuclear compartment within the cell, and the suggestion of 
some traffic to the plasma membrane of the presenilin (figure 3 IB), an effect similar 
to that seen with KChIP3 (figure 25C).
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Figure 27. Localisation and expression of NCS-l-ECFP in COS-7 cells.
COS-7 cells were transfected with ECFP-tagged NCS-1 and imaged 48 hours 
post-transfection (A). NCS-1 is localised to the Golgi and plasma membrane. 
(B) Western blot to show NCS-l-ECFP expression in COS-7 cells. ECFP is 
shown as a comparison.
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Figure 28. Effect of co-expression of NCS-l-ECFP and Kv4.2-pcDNA in COS-7 
cells on their localisation.
COS-7 cells were co-transfected with NCS-l-ECFP and Kv4.2 before imaging 48 
hours post-transfection. Cells were fixed and immunostained with anti-Kv4.2 
antibody, using a Dylight secondary in order to detect the channel. Two examples are 
shown (A and B). Co-expression of the proteins caused some association of Kv4.2 
with the plasma membrane (A) although this trafficking effect is not always evident 
(B). The colour overlays show NCS-l-ECFP in green and Kv4.2 in red, with overlap 
seen in yellow.
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Figure 29. Effect of co-expression of NCSl-eCFP and Kvl.4-eGFP in COS-7 
cells on their localisation.
COS-7 cells were cotransfected with NCS-l-ECFP and Kvl.4-EGFP. NCS-1 does 
not appear to have a clear effect on the localisation of Kvl.4. Two examples are 
shown (A and B). In some cases, an effect can be seen, with the channel remaining 
trapped in the ER/Golgi region of the cell (A). Conversely however, the channel can 
also be found to be clearly localised to the plasma membrane of some cells, 
suggesting no effect on its traffic due to NCS-1 (B). The overlays show NCS-1 in 
red and Kvl.4 in green, with overlapping areas appearing yellow.
Figure 30. Co-expression of NCS-l-ECFP and Kvl.5-EGFP in COS-7 cells does 
not stimulate traffic of Kvl.5 to the plasma membrane.
COS-7 cells were transfected to co-express Kvl.5-EGFP and NCS-l-ECFP and 
imaged 48 hours post-transfection. NCS-1 does not stimulate traffic of the channel to 
the plasma membrane, with the channel remaining in the Golgi region of the cell and 
the NCS-lbeing localised to both the Golgi and the plasma membrane. The colour 
overlay shows the NCS-l-ECFP in red and the channel in green, with regions of 
overlap in yellow.
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AFigure 31. Effect of co-expression of NCS1-ECFP and PS1-EGFP in COS-7 
cells on their localisation.
COS-7 cells were co-transfected to express both NCS-l-ECFP and PS1-EGFP. Two 
examples are shown (A and B). Some cells co-expressing the proteins appear to show 
no change in the individual localisation of the individual proteins (A) with NCS-1 
found in the Golgi region and on the plasma membrane and presenilin-1 appearing 
to be reticular. However, some cells appear to suggest a change in the localisation of 
presenilin-1 (B) with the presenilin co-localising with the NCS-1 in the TGN and the 
suggestion of some plasma membrane localisation. The colour overlay shows NCS-1 
in red, presenilin-1 in green and areas of overlap in yellow.
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3.3 Discussion
The results presented here demonstrate that whilst the KChIPs do possess the ability 
to perform multiple functions in common with each other, they also maintain distinct 
functions specific to themselves. Whilst all four KChIPs can stimulate the traffic of 
the Kv4.2 channel to the plasma membrane, only KChIP2 seems to have a 
regulatory role with respect to Kvl .4 channels whilst only KChIP3 (and to a lesser 
extent KChIPl) appears to interact with presenilin-1. The results on potential 
interactions are summarised on Table 1. It is important that it is noted that a 
significant limitation of this study is that it is based only on co-localisation or 
changes in localisation and was based on a non-quantitative assessment. It cannot be 
ruled out that interactions occurred that did not produce obvious effects detectable 
by imaging.
Kvl .4 Kvl.5 Kv4.2 PS1
KChIPl - “ ++ -
KChIP2 + - ++ -
KChEP3 - - ++ ++
KChIP4 - - ++ -
NCS-1 +/- “ +/- +/-
Table 1. Summary of potential interactions of the KChIPs and NCS-1 with K+ 
channels and presenilin based on localisation studies. ++ indicates a strong 
suggestion of interaction, + a potential interaction and -  no evidence of interaction.
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The importance of different splice variants of the KChIPs is something that remains 
unclear and yet something that might assume particular relevance with regards to 
their function. Literature on the KChIP splice variants is confusing due to differing 
nomenclature being used to describe the same variant which makes dissecting 
isoform specific effects difficult, especially when it is not clear which isoform has 
been used in a particular study. However, it is becoming apparent that different 
isoforms can display different effects. A study comparing the effects of KChIP 1 
splice variants upon the rate of recovery from inactivation of Kv4 channels found 
significant differences between KChIP 1.1 and KChIP 1.2 (Van Hoorick et al., 2003), 
whilst several studies on KChIP2 isoforms have demonstrated differences in the 
efficiency of stimulating the traffic of Kv4 channels to the cell surface (Deschenes et 
al., 2002; Decher et al., 2004; Patel et al., 2004). Furthermore, whilst most KChIP 
isoforms apparently act to stimulate traffic of Kv4 channels to the cell surface, one 
KChIP2 isoform has been shown to inhibit Kv4 surface expression (Patel et al., 
2002), and one KChIP4 isoform has no effect on channel trafficking and leads to the 
complete abolition of the fast activation of Kv4 channels (Holmqvist et al., 2002).
The variable effects of these different isoforms become more intriguing when you 
consider the interaction of the KChIPs with the Kv4 channels. Interaction of the two 
proteins results in the formation of an octomeric structure that consists of four 
KChIP and four Kv channel subunits (Kim et al., 2004b; Pioletti et al., 2006). It is 
known that KChIPs can form homo- or hetero-oligomers (Osawa et al., 2001), 
which thus raises the question of whether or not functional KChIP-Kv4 complexes
114
could contain multiple KChIP isoforms, thus resulting in subtle variations in channel 
expression and function. Analysis of the expression of the four KChIP genes 
showed major regional differences in their expression in the brain (Pruunsild & 
Timmusk, 2005), whilst the use of antisera specific for KChIP 1-4 indicated a cell- 
type-specific expression of the four KChIPs in the cerebellum, cortex striatum and 
hippocampus (Rhodes et al., 2004; Strassle et al., 2005). It would be interesting 
however to discover the differing expression of each of the splice variants -  it is 
possible that specific KChIP isoforms are limited to particular neuronal cell types 
together with specific Kv4 channel isoforms to modulate their function as desired for 
that individual cell type?
The differing intracellular localisation of the KChIPs is something that may also be 
important in maintaining subtle functional differences. As I demonstrated here, 
KChIP 1.2 is targeted to a population of intracellular vesicles when expressed in 
COS-7 cells, and this is targeting is believed to increase the efficiency of trafficking 
Kv4 channels to the plasma membrane relative to the other KChIPs (An et al.,
2000). However, despite differential cellular localisation, it is clear that KChIP 2.3 
(membrane associated), and KChIPs 3.1 and 4.1 (cytosolic) can all carry out this 
particular functional role. It is quite possible that these differences in intracellular 
targeting, together with cell-type specific expression of different KChIPs and 
different isoforms are important in terms of regulating specific channel isoforms in 
specific cell types. It was surprising that KChIPs 2,3 and 4 were not all membrane 
associated when expressed alone as they all possess palmitoylation motifs.
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Palmitoylation is required for the ability of KChIPs 2 and 3 to stimulate traffic of 
Kv4.2 channels to the plasma membrane (Takimoto et al., 2002)
The importance of the interaction of the KChIPs with the presenilins is not entirely 
clear. Whilst I demonstrated a change in localisation of the two proteins when 
KChIP3 and presenilin-1 were co-expressed in COS-7 cells, I was unable to see a 
similar change in localisation with KChIP4, and whilst observing some intracellular 
changes in localisation with KChIPl, I was unable to confirm previous work 
suggesting an interaction between KChIP 4, and presenilin-1 (Morohashi et al., 
2002), neither by confocal microscopy nor by co-immunoprecipitation (data not 
shown). Undoubtedly, the significance of the interaction between KChIP3, and 
potentially the other KChIPs, with respect to the functional role of the presenilins is 
something that requires further investigation. Given the widespread expression of 
both presenilins 1 and 2 throughout the brain compared to the more cell type specific 
expression of the KChIPs, it might make sense that multiple KChIPs can interact 
with the presenilins if this interaction is functionally significant.
It is still unclear as to whether KChIPs have distinct or overlapping roles. Whilst I 
have demonstrated that isoforms of all KChIPs can modulate Kv4 channel 
trafficking, and it has been reported that isoforms of all four KChIPs have DREAM 
activity (Link et al., 2004), I have also shown that not all KChIPs appear to interact 
with Kvl channels, nor do they all appear to interact with presenilin-1. The KChIPs 
may not all have overlapping function as knock-outs of KChIP2 and KChIP3 both
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lead to differing and non-compensated phenotypes (Kuo et al., 2001; Cheng et al., 
2002; Lilliehook et al., 2003). However, this non-redundancy may be due to 
differential expression of KChIPs in different cell types. The need for multiple 
KChIPs may be due to specific neuronal expression patterns to allow subtle 
differences in the fine tuning of channel function for example, in different neuronal 
cell types. Thus the extent to which KChIP functions overlap or are distinct is 
something that remains to be fully elucidated.
KChIPs are not the only NCS proteins that are able to modulate Kv4 channels, with 
NCS-1 previously reported to have the ability to regulate these channels. The 
findings of previous studies have, however, been somewhat contradictory. Some 
groups suggest that NCS-1 has similar effects to KChIPs, although the increase in 
current density prompted by NCS-1 is not as large as with the KChIPs (Guo et al., 
2002; Nakamura et al., 2003). By contrast, another study found that in lobster 
pyloric neurons, NCS-1 was ineffective in increasing current density (Zhang et al., 
2003), whilst a further study was unable to confirm a direct interaction between 
NCS-1 and Kv4 channels (Ren et al., 2003). Thus the precise role that NCS-1 may 
play in regulating Kv4 membrane traffic and any physiological relevance of this 
interaction remains controversial. I have found that in COS-7 cells, NCS-1 is not 
only able to stimulate Kv4 traffic, but may also have the ability to regulate Kvl.4 
traffic, and furthermore, potentially interact with presenilin-1. Some of the 
observations made are however, less than clear cut, and it would appear that
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although NCS-1 apparently has the ability to carry out functions similar to those of 
the KChIPs, but is less effective at doing so. Whether this lower effectiveness is a 
result of differential intracellular targeting, a lower affinity of NCS-1 for the 
aforementioned proteins, variable intracellular conditions or potentially as a result of 
the multiple functionality of NCS-1 is unknown. The significance of these potential 
interactions for the physiological functions of NCS-1 is unclear, and would require 
further work in order to be resolved.
The results presented here raise the possibility that KChIPs carry out multiple 
cellular functions that in some cases overlap amongst the KChIPs and also with 
NCS-1. Given the potential overlap between NCS-1 and KChIP function, and the 
reported ability of NCS-1 to stimulate regulated exocytosis in a well defined assay, 
the effect of KChIPs on exocytosis was subsequently examined.
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CHAPTER 4:
Differential effects of KChIP3 on 
calcium signalling and regulated 
secretion in PC 12 cells
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4.1 Introduction
Given the potential for the overlap of functions between NCS-1 and the KChIPs, I 
set out to investigate another known function of NCS-1, its role in stimulating 
regulated exocytosis, and whether or not the KChIPs also shared this particular 
functional property using a well established assay.
Regulated exocytosis of neurotransmitters and hormones during neurosecretion is 
triggered by a rise in cytosolic Ca2+ concentration (Burgoyne & Morgan, 1995), and 
in the multiple stages of the exocytotic pathway (Martin, 1997; Burgoyne &
Morgan, 1998), it is likely that both secretory vesicle recruitment and membrane 
fusion are regulated by Ca2+. Whilst the main Ca2+ binding protein involved in 
exocytosis would appear to be the low affinity Ca -binding protein synaptotagmin I 
(DiAntonio et al., 1993; Littleton et al., 1993; Geppert et al., 1994), there are 
multiple stages throughout the exocytotic pathway where other Ca2+ -binding 
proteins may play an important role. The NCS proteins are well suited to respond to 
small increases in Ca that enhance exocytosis from nerve endings due to their high 
affinity for Ca , and indeed, overexpression of NCS-1 has been shown to enhance 
evoked neurotransmitter release, paired-pulse facilitation and exocytosis in several 
neuronal and neuroendocrine cell types (Pongs et al., 1993; McFerran et al., 1998; 
Haynes et al., 2005). The mechanism by which this stimulation of release occurs is 
not entirely clear. The current data suggest that NCS-1 may potentiate secretion 
from a variety of cell types by enhancing the trafficking of TGN-derived transport
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carriers via activation of PI4KP, with possible additional role(s) in modulating 
channels and/or receptors through direct and/or indirect interactions (Hilfiker, 2003).
To probe the effect of KChIP over-expression on secretion I made use of an assay in 
which cells were co-transfected so that they expressed human growth hormone (GH) 
as well as a test protein of choice. GH is not normally expressed by these cells but in 
transfected cells is packaged into dense core granules and secreted in response to 
Ca2+ elevation (Wick et al., 1993). This system was used to first demonstrate the 
stimulatory effect on regulated secretion due to NCS-1 over-expression and utilises 
the PC 12 cell line, which has previously proved to be a good model for the study of 
neurosecretion (McFerran et al., 1998). Co-transfection with a plasmid encoding 
growth hormone has been widely used in the study of proteins involved in dense- 
core granule exocytosis in PC12 cells (Chung et al., 1995; Orita et al., 1996; 
Graham et al., 1997; Orita et al., 1997; Wang et al., 1997). Transfection using 
LipofectAMINE (Invitrogen) results in transfection of up to 10% of the PC 12 cells 
(Graham et al., 1997), with the assay of GH release allowing analysis of only those 
cells that have taken up the plasmid. It has previously been demonstrated that 
essentially all cells expressing GH will also express the second transfected protein 
(McFerran et al., 1998).
The potential for the KChIPs to play a role in neurosecretion is further enhanced by
o  i
the knowledge that certain KChIPs have previously been shown to modulate Ca 
signalling in other cell types (Lilliehook et al., 2002), and thus may be ideally suited
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to respond to and modulate Ca levels during the process of exocytosis. 
Furthermore, the KChIPs share the DREAM function and are able to repress
2  j
transcription, something that has been implied as being important in relation to Ca 
-signalling through a reduction of the expression of the Na/Ca2+ exchanger NCX3 
due to a direct repression of its transcription (Gomez-Villafuertes et al., 2005).
Here I aimed to not only investigate effects of the overexpression of the KChIPs on 
neurosecretion, but subsequently their effects on the intracellular Ca2+ changes 
elicited during ATP stimulation of purinergic receptors on the cells.
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4.2 Effects of the KChIPs on regulated secretion
4.2.1 The KChIPs express to comparable levels in PC12 cells
Before carrying out experiments to directly compare the KChIPs in a functional 
assay, it was important to confirm that the four KChIP constructs that would be used 
in the experiments were expressed to the same level once transiently transfected into 
PC 12 cells so that any differences observed could not be down to a difference in 
expression of the proteins. Previous investigation of protein expression in 
transfected PC12 cells by Western blot analysis was inconclusive (figure 11). When 
blotted using an anti-GFP antibody, it would appear that KChIP2-ECFP and 
KChIP3-ECFP were expressed to a higher level than KChIP 1-ECFP and KChIP4- 
ECFP. However, when identical volumes of the same cell lysates were run on a 
different gel and the subsequent blot probed with an anti-pan KChIP antibody, 
KChIPs 1, 2 and 4 all expressed to a comparable level, with KChIP3 not really 
detected at a significant level.
In order to confirm expression levels were at a similar intensity in PC 12 cells, cells 
were transfected with 2pg of either one of the four KChIP-ECFP plasmids or with 
2pg of control ECFP-N1 plasmid and imaged using confocal microscopy 48 hours 
post transfection. All microscope settings were kept constant when carrying out the 
cellular imaging, and from the images obtained, the relative fluorescence of
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transfected cells was calculated by drawing regions of interest around transfected 
> cells and measuring the fluorescence from each cell.
For reasons that were unclear, transfection with ECFP-N1 alone resulted in a higher 
level of fluorescence expressed. Cells transfected with the four ECFP-tagged 
KChIPs fluoresced to an equivalent mean level (figure 32), and thus illustrated their 
|  suitability for use and direct comparison in the subsequent growth hormone and X-
rhod-1 imaging.
>
124
250-,
0o
c0oV)
0
(0
200-
150-
100-
p < 0 .0 0 1
KChIPI KChlP2 KChlP3 KChlP4 ECFP-N1
» Figure 32. All KChIP ECFP-tagged constructs fluoresce to a comparable level
in PC12 cells.
PC 12 cells were transfected to express ECFP-tagged KChIPs 1-4 or a control 
ECFP-N1 plasmid. Live cells were imaged 48 hours post-transfection under identical 
microscope and laser conditions. The microscope settings for the experiment were 
as follows - the Leica CS-SP-MP microscope was utilised with cells excited at 430nm 
and light collected at 460-5 lOnm. The laser power was maintained at 30.38%, the gain 
set at 931.4V, the beam expansion set at 6, the beam splitter used RSP455, the 
pinhole(M) at 143.02pm and the pinhole(AU) at 1.07 airy. After completion of the 
> experiment, average values were collected for whole cell fluorescence for transfected
cells. The number of cells for each condition were as follows: KChIP 1 15 cells, 
KChIP2 12, KChIP3 24, KChIP4 18, ECFP-N1 23.
►
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PC 12 cells were transfected to express GH (human growth hormone plasmid) and 
each of the KChIPs as FLAG-tagged constructs, and GH secretion was assayed 
under basal conditions and in response to activation of purinergic receptors by the 
addition of 300pM ATP, described by McFerran et al, 1998. Neither cells 
transfected with the control FLAG plasmid, nor cells transfected with any of the 
FLAG-tagged KChIPs exhibited a significant difference in the amount of basal GH 
release, expressed as a percentage of total cellular GH levels. However, whilst the 
control FLAG plasmid and FLAG-tagged KChIPs 1, 2 and 4 all displayed similar 
amounts of GH release in response to ATP-stimulation, FLAG-KChIP3 specifically 
and significantly increased the level of GH release (figure 33).
4.2.2 FLAG-KChIP3 increases secretion from PC12 cells in response to
activation of purinergic receptors
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Figure 33. Overexpression of KChIP3, but none of the other KChIPs, increases 
reporter growth hormone release from PC12 cells.
PC 12 cells were transfected with either FLAG plasmid as a control, or with one of 
the FLAG-KChIP encoding plasmids, together with GH-encoding plasmid. After 2 
days, cells were washed and incubated with no additions or with 300pM ATP for 15 
minutes. (A) Growth hormone release was then assayed and expressed as a percentage 
of total cellular GH levels (n=4). Compared to the control plasmid, KChIP3 
significantly enhances GH release from the cells, and this effect is specific for 
KChIP3 with none of the other KChIPs inducing any change in GH release compared 
to the control plasmid. (B) Total cellular growth hormone content (pg).
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Given that the FLAG-tag constructs have the tag at the N-terminus, I wanted to 
confirm that the FLAG-tag was not affecting the results obtained in any way, as the 
presence of the FLAG-tag at the N-terminus would prevent the myristoylation of 
KChIPl, something that is important for its membrane targeting (O'Callaghan et al., 
2003a), and could affect palmitoylation of KChIPs2-4, which although apparently 
not as important in the intrinsic targeting of the proteins (at least in the case of 
KChIPs 3 and 4), may have importance with respect to the functional affects of the 
proteins.
Secretion assays were therefore carried out using cells co-transfected with GH and 
either KChIPl-pcDNA or KChEP3-pcDNA respectively to allow expression of 
untagged proteins. Again, in the case of basal GH release, neither expression of 
KChIPl-pcDNA nor expression of KChIP3-pcDNA produced a change in basal GH 
release relative to the control plasmid (empty pcDNA vector). However, when the 
cells were stimulated with 300pM ATP, KChIPl-pcDNA failed to elicit a significant 
change in amount of GH secreted relative to the control, whilst KChIP3-pcDNA 
transfected cells again showed an enhanced level of GH secretion (figure 34).
For the purposes of use in later experiments, assays were then completed to confirm 
whether or not the presence of an ECFP-tag on the C-terminus of the protein would
4.2.3 Overexpression of KChIP3 increases secretion from PC12 cells in
response to ATP-stimulation
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have any effect on the effects seen on ATP-stimulated secretion. KChIP3-ECFP, 
KChIP3-pcDNA and FLAG-KCMP3 all exhibited a comparable escalation of GH 
release from PC12 cells when stimulated by 300pM ATP, whilst showing no change 
in basal release of GH (figure 35). This illustrated that the presence of an ECFP-tag 
on the C-terminus of the protein (or indeed the presence of a small FLAG-tag on the 
N-terminus) had no effect on the level of secretion, and thus ECFP-tagged proteins 
were suitable for use in further secretion assay experiments.
Multiple assays were carried out using the ECFP-N1 vector as a control plasmid and 
KChEP3-ECFP as the test plasmid and the data from all experiments were pooled. 
Whilst the basal levels of secretion did not significantly differ between the control 
and test plasmids, an increase in GH release was observed in cells transfected with 
KChIP3-ECFP in response to stimulation with 300pM ATP (figure 36), confirming 
that KChIP3 can act to elicit an increase in stimulated exocytosis in intact PC 12 
cells.
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Figure 34. Overexpression of KChIP3 but not KChIPl increases reporter 
growth hormone release from PC12 cells.
PC 12 cells were transfected with either pcDNA3 plasmid as a control or with 
either KChIP3-pcDNA or KChIPl-pcDNA, together with GH-encoding plasmid. 
After 2 days, cells were washed and incubated with no additions or with 300pM ATP 
for 15 minutes. (A) Growth hormone release was then assayed and expressed as a 
percentage of total cellular GH levels (n=9). Compared to the control plasmid, 
KChIP3 but not KChIPl significantly enhances GH release from the cells.
(B) Total cellular growth hormone levels (pg).
130
p < 0 .0 2
pcDNA
transfected
KChlP3-pcDNA
transfected
KChlP3-ECFP
transfected
FLAG-KChlP3
transfected
B 2500 -i
pcDNA control KChlP3-pcDNA KChlP3-ECFP pFLAG-KChlP3
Figure 35. Overexpression of KChIP3 increases reporter growth hormone release 
from PC12 cells.
PC 12 cells were transfected with either ECFP-N1 plasmid as a control, or with one 
of a variety of KChIP3 encoding plasmids, together with GH-encoding plasmid. After 
2 days, cells were washed and incubated with no additions or with 300pM ATP for 
15 minutes. (A) Growth hormone release was then assayed and expressed as a 
percentage of total cellular GH levels (n=3). Compared to the control plasmid,
KChIP3 significantly enhances GH release from the cells, with this effect being 
similar for each KChIP3 encoding plasmid tested. (B) Total growth hormone levels
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Figure 36. Overexpression of KChIP3 increases reporter growth hormone 
release from PC12 cells.
PC 12 cells were transfected with either ECFP-N1 plasmid as a control or with 
KChIP3-ECFP, together with GH-encoding plasmid. After 2 days, cells were washed 
and incubated with no additions or with 300pM ATP for 15 minutes. (A) Growth 
hormone release was then assayed and expressed as a percentage of total cellular GH 
levels (n=12). Compared to the control plasmid, KChIP3 significantly enhances GH 
release from the cells. (B) Total growth hormone levels (pg).
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Previous studies on NCS-1 have demonstrated that NCS-1 results in an increase in 
stimulated exocytosis in intact though not in permeabilised PC 12 cells where Ca2+ 
directly triggered exocytosis, implicating NCS-1 as a general but indirect regulator 
of neurosecretion (McFerran et al., 1998). In order to investigate whether or not 
KChIP3 acted in a similar indirect manner, PC 12 cells were transfected with either 
KChIP3-ECFP or ECFP-N1 as a control. Two days after transfection the cells were 
washed, permeabilised with digitonin and incubated in the presence of 0 or 10 |iM 
free Ca for 15 minutes (Graham et al., 2000). Growth hormone release was assayed 
and expressed as a percentage of total cellular GH levels (figure 37). Cells 
transfected with ECFP-N1 and KChIP3-ECFP showed no significant differences in 
the amount of GH release in the presence of OpM free Ca2+. When the free Ca2+ 
concentration was increased to 10 pM, again no significant difference in GH release 
was observed, thus illustrating that KChIP3 overexpression causes an increase in 
stimulated exocytosis in intact but not permeabilised PC 12 cells, similar to NCS-1.
4.2.4 Overexpression of KChIP3 has no effect on the amount of reporter
growth hormone release from permeabilised PC12 cells
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AFigure 37. Lack of effect of overexpression of KChIP3 on reporter growth 
hormone release from permeabilised PC12 cells.
PC 12 cells were transfected with either ECFP-N1 plasmid as a control or with 
KChIP3-ECFP, together with GH-encoding plasmid. After 2 days, cells were washed 
and permeabilised for 6 minutes by incubation with 20pM digitonin. (A) The cells 
were then challenged with either 0 or lOpM free Ca2+ and growth hormone release 
during a 15 minute period assayed and expressed as a percentage of total cellular GH 
levels (n=6). Compared to the control plasmid, KChIP3 does not exhibit an effect on 
GH release from permeabilised cells. (B) Total cellular growth hormone levels (pg).
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KChIP3 is known to interact with presenilin 1 and 2 (Buxbaum et al., 1998) and the 
presenilins have been shown to affect ER Ca2+ by having a Ca2+ leak function (Tu et 
al., 2006; Nelson et al., 2007). Presenilins are widely expressed and, therefore, it
was possible that the effect of KChIP3 secretion could have been due to an
2+interaction with presenilin and a subsequent alteration of intracellular Ca 
signalling.
To investigate this possibility further, PC 12 cells were transfected to express either a 
control plasmid (ECFP-N1), presenilin 1-EGFP or a combination of presenilin- 
EGFP and KChIP3-ECFP, together with GH plasmid. Two days after transfection, 
cells were washed with Krebs buffer and incubated with no additions (basal) or with 
300pM ATP for 15 minutes. Growth hormone release was assayed and expressed as 
a percentage of total cellular GH levels.
Overexpression of presenilin 1 -EGFP produced no significant effect on either basal 
or stimulated GH release. The results of several assays were pooled and are 
displayed (figure 38). Furthermore, expression of presenilin-1 in combination with 
KChLP3 did not modify the GH secretion enhancement observed with KChIP3 
(figure 39).
4.2.5 Expression of presenilin 1-EGFP has no effect on stimulated exocytosis
from intact PC 12 cells
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Figure 38. Overexpression of presenilin-1 has no effect on reporter growth 
hormone release from PC12 cells.
P PC 12 cells were transfected with either presenilin 1 -EGFP plasmid or ECFP-N1
plasmid as a control, together with GH-encoding plasmid. After 2 days, cells were 
washed and incubated with no additions or with 300pM ATP for 15 minutes.
(A) Growth hormone release was then assayed and expressed as a percentage of total 
cellular GH levels (n=18). Compared to the control plasmid, presenilin-1 does not 
exhibit an effect on GH release from the cells. (B) Total cellular growth hormone 
levels (pg).
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Figure 39. Overexpression of KChIP3 increases reporter growth hormone release 
from PC12 cells and this effect is unaltered by co-expression of presenilin-1.
PC 12 cells were transfected with either ECFP-N1 plasmid as a control, KChIP3-ECFP 
or a combination of both KChIP3-ECFP and PS1-EGFP, together with GH-encoding 
t  plasmid. After 2 days, cells were washed and incubated with no additions or with
300p.M ATP for 15 minutes. (A) Growth hormone release was then assayed and 
expressed as a percentage of total cellular GH levels (n=12). Compared to the control 
plasmid, KChIP3 significantly enhances GH release from the cells. However, this effect 
is neither enhanced or diminished by co-expression of presenilin-1. (B) Total growth 
hormone levels (pg).
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Perhaps the best characterised of the KChIP functions is the interaction with the Kv4 
channels. It was possible that the effect of KChIP3 secretion could have been due to 
an interaction with the Kv4 channels and a subsequent affect on cellular excitability 
and potentially Ca signalling.
To investigate this possibility further, PC 12 cells were transfected to express either a 
control plasmid (ECFP-N1), ECFP-Kv4.2 or a combination of ECFP-Kv4.2 and 
KChIP3-ECFP, together with GH plasmid. Two days after transfection, cells were 
washed with Krebs buffer and incubated with no additions (basal) or with 300pM 
ATP for 15 minutes. Growth hormone release was assayed and expressed as a 
percentage of total cellular GH levels.
Overexpression of ECFP-Kv4.2 produced no significant effect on either basal or 
stimulated GH release. Furthermore, expression of ECFP-Kv4.2 in combination 
with KChEP3 did not modify the GH secretion enhancement observed with KChIP3 
(figure 40).
4.2.6 Expression of ECFP-Kv4.2 has no effect on the amount of growth
hormone release from PC12 cells in response to ATP stimulation
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Figure 40. Overexpression of Kv4.2 has no effect on reporter growth hormone 
release from PC12 cells.
PC 12 cells were transfected with either ECFP-Kv4.2 plasmid, ECFP-N1 plasmid 
as a control or a combination of ECFP-Kv4.2 and KChIP3-ECFP, together with 
GH-encoding plasmid. After 2 days, cells were washed and incubated with no 
additions or with 300pM ATP for 15 minutes. (A) Growth hormone release was then 
assayed and expressed as a percentage of total cellular GH levels (n=9).
Compared to the control plasmid, Kv4.2 does not exhibit an effect on 
GH release from the cells. (B) Total cellular growth hormone levels (pg).
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4.3 The effects of the KChIPs on Ca2+ signalling in response to purinergic
stimulation
4.3.1 Overexpression of KChIP3 but none of the other KChIPs delays the 
decline of cytosolic Ca concentration from the peak after stimulation with 
ATP
Overexpression of KChIP3 has previously been demonstrated to cause an increase in 
the Ca2+ content of the ER and to reduce the expression of the plasma membrane 
Na /Ca exchanger NCX3. It is therefore possible that the effect seen on GH 
secretion could be due to an effect on Ca2+ signalling within the cell following ATP 
stimulation. In order to test this, cells were transfected with ECFP-tagged KChIPs, 
the cells loaded with the calcium indicator X-Rhod-1 and the changes in the 
intracellular Ca concentration in response to ATP monitored following previously 
published methodology (Haynes et a l, 2004).
Firstly however, it was important to establish that expression of ECFP protein itself 
didn’t have an effect on [Ca ]i responses to ATP. In cells expressing ECFP alone, 
robust [Ca ]i rises in response to perfusion with 300pM ATP were observed that 
were almost identical to responses recorded from adjacent control, nontransfected 
cells monitored simultaneously from the same coverslips (figure 41). This result 
showed that transfection and expression of ECFP did not adversely affect normal 
rises in [Ca ];. Averaged peak responses from a number of cells confirmed no
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statistical difference in peak [Ca2+]i responses to ATP between ECFP-transfected and 
nontransfected cells (figure 41).
In order to compare the effects of each of the KChIPs, cellular fluorescence levels of 
X-Rhod-1 were monitored before, during and after stimulation in high ECFP- 
expressing cells and adjacent nontransfected cells, and the data for expressed and 
nontransfected cells directly compared. Expression of KChIPs 1-4 had no significant 
effect on the peak increase in [Ca2+]i following the addition of 300pM ATP (figures 
42-45). KChIPs 1, 2 and 4 had no effect on any other aspect of the Ca2+ signal 
(figures 42, 43 and 45). However, KChIP3-ECFP expression resulted in a 
significantly elevated [Ca2+]i during the latter period of the experiment as the [Ca2+]i 
was slowly declining (figure 44).
The data from analysis of the effect of KChIPs on changes in [Ca2+]i would be 
consistent with the possibility that the increased GH secretion in KChIP3 expressing 
PC12 cells was a result of the prolongation of the increased [Ca2+]i observed at later 
times of stimulation.
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KChlP1-ECFP X-Rhod-1 Basal X-Rhod-1 +ATP
Figure 40. Expression of KChIPl has no effect on cytosolic Ca2+concentration in 
comparison to control cells after stimulation with ATP.
PC 12 cells were transfected to express KChIPl as an ECFP tagged construct. 48 hours 
after transfection cells were loaded with X-rhod-1 AM and then live cells were imaged. 
An ECFP image was taken to allow identification of transfected and non-transfected 
cells and then X-rhod-1 fluorescence was monitored before and after stimulation by 
perfusion with 300pM ATP. Images of ECFP and X-rhod-1 before and at the peak after 
stimulation are shown.After completion of the experiment average values were collected 
for whole cell fluorescence for transfected and adjacent control cells. Fluorescence 
values were normalised to the initial fluorescence for each cell and the data are shown 
as mean + SEM. The numbers of cells for each condition were as follows:
KChIPl, 19 control, 17 transfected.
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Figure 41. Expression of KChIP2 has no effect on cytosolic Ca2+concentration in 
comparison to control cells after stimulation with ATP.
PC 12 cells were transfected to express KChIP2 as an ECFP tagged construct. 48 
hours after transfection cells were loaded with X-rhod-1 AM and then live cells were 
imaged. An ECFP image was taken to allow identification of transfected and non- 
transfected cells and then X-rhod-1 fluorescence was monitored before and after 
stimulation by perfusion with 300pM ATP. Images of ECFP and X-rhod-1 before and 
at the peak after stimulation are shown. After completion of the experiment average 
values were collected for whole cell fluorescence for transfected and adjacent control 
cells. Fluorescence values were normalised to the initial fluorescence for each cell 
and the data are shown as mean ± SEM. The numbers of cells for each condition were 
as follows: KChIP2, 35 control, 29 transfected.
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Figure 42. Expression of KChIP-3 delays the decline of cytosolic Ca2+ 
concentration from the peak after stimulation with ATP.
PC 12 cells were transfected to express KChIP3 as an ECFP tagged construct. 48 
hours after transfection,cells were loaded with X-rhod-1 AM and then live cells were 
imaged. An ECFP image was taken to allow identification of transfected and 
non-transfected cells and then X-rhod-1 fluorescence was monitored before and after 
stimulation by perfusion with 300pM ATP. Images of ECFP and X-rhod-1 before and 
at the peak after stimulation are shown. After completion of the experiment average 
values were collected for whole cell fluorescence for transfected and adjacent control 
cells. Fluorescence values were normalised to the initial fluorescence for each cell and 
the data are shown as mean ± SEM. The numbers of cells for each condition were as 
follows: KChIP3, 19 control, 21 transfected.
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KChlP4-ECFP X-Rhod-1 Basal X-Rhod-1 +ATP
Figure 43. Expression of KChIP4 has no effect on cytosolic Ca2+concentration in 
comparison to control cells after stimulation with ATP.
PC 12 cells were transfected to express KChIP4 as an ECFP tagged construct. 48 
hours after transfection cells were loaded with X-rhod-1 AM and then live cells were 
imaged. An ECFP image was taken to allow identification of transfected and non- 
transfected cells and then X-rhod-1 fluorescence was monitored before and after 
stimulation by perfusion with 300pM ATP. Images of ECFP and X-rhod-1 before 
and at the peak after stimulation are shown. After completion of the experiment 
average values were collected for whole cell fluorescence for transfected and 
adjacent control cells. Fluorescence values were normalised to the initial fluorescence 
for each cell and the data are shown as mean + SEM. The numbers of cells for each 
condition were as follows: KChIP4, 22 control, 22 transfected.
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Figure 44. Expression of ECFP-N1 has no effect on Ca2+concentration after 
stimulation with ATP in comparison to nontransfected control cells.
PC 12 cells were transfected to express ECFP-N1 and 48 hours after transfection were 
loaded with X-rhod-1 AM and then live cells were imaged. An ECFP image was taken 
to allow identification of transfected and non-transfected cells and then X-rhod-1 
fluorescence was monitored before and after stimulation by perfusion with 300pM 
ATP. Images of ECFP and X-rhod-1 before and at the peak after stimulation are shown. 
After completion of the experiment average values were collected for whole cell 
fluorescence for transfected and adjacent control cells. Fluorescence values were 
normalised to the initial fluorescence for each cell and the data are shown as mean 
±  SEM. The numbers of cells for each condition were 33 control and 28 transfected.
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4.3.2 Overexpression of presenilin 1-EGFP has no effect on Ca2+ 
concentration after stimulation with ATP
To confirm that the effect of KChIP3 seen upon secretion and the intracellular Ca 
concentration in PC 12 cells in response to the addition of ATP related to an 
interaction with presenilin-1, after testing the effect of presenilin-1 overexpression 
on secretion (figures 38 and 39) the effect of presenilin-1-EGFP overexpression on 
the ATP evoked elevation of [Ca ], was investigated.
X-rhod-1 fluorescence was recorded before, during and after stimulation of cells 
either strongly expressing presenilin-1-EGFP or control nontransfected cells with 
300pM ATP. Expression of presenilin-1-EGFP did not significantly alter the peak 
[Ca ]i nor did it affect the duration of the elevation, with the rate of decline 
exhibited comparable to that of the control nontransfected cells (figure 45).
These data suggest that the effects seen on both secretion and upon the [Ca2+]¡ 
following stimulation with ATP in cells overexpressing KChIP3 would not appear to 
be due to an interaction between KChIP3 and presenilin-1.
2 +
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Figure 45. Expression of presenilin-l-EGFP has no effect on Ca2+concentration 
after stimulation with ATP.
PC 12 cells were transfected to express presenilin-l-EGFP (PS1-EGFP) and 48 hours 
after transfection were loaded with X-rhod-1 AM and then live cells were imaged.
An EGFP image was taken to allow identification of transfected and non-transfected 
cells and then X-rhod-1 fluorescence was monitored before and after stimulation by 
perfusion with 300pM ATP. Images of EGFP and X-rhod-1 before and at the peak 
after stimulation are shown. After completion of the experiment average values were 
collected for whole cell fluorescence for transfected and adjacent control cells. 
Fluorescence values were normalised to the initial fluorescence for each cell and 
the data are shown as mean ± SEM. The numbers of cells for each condition were 
28 control and 26 transfected.
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4.4 Discussion
In this study I have demonstrated a specific effect for expression of KCMP3 
compared to isoforms of KChIPs 1,2 and 4 on Ca2+ responses to purinergic receptor 
stimulation and on secretion in PC12 cells. Although I cannot formally prove that 
the effects seen upon secretion are as a direct result of the modification of the Ca2+ 
signal seen in response to ATP stimulation, this does seem likely, particularly as the
2*heffect of KChIP3 is not seen in permeabilised cells in response to buffered Ca 
concentration. If the increased secretion of GH observed were as a result of the 
prolonged increase in [Ca2+]i then secretion directly triggered by an increasing Ca2+ 
to a fixed level should not be affected by KChIP3 expression, as demonstrated by 
these experiments.
Previous studies have highlighted that KChIP3 can have an effect on Ca2+ signalling; 
this has been attributed in one study to an increase in the filling of ER Ca stores 
(Lilliehook et a l, 2002), whilst another investigation found that expression of a 
dominant active EF-hand mutant of KChIP3 resulted in the slowing of recovery 
from Ca2+ elevation in cerebellar granule cells (Gomez-Villafuertes et al., 2005).
The latter finding was attributed to the DREAM function of KChIP3, resulting in 
lower expression levels of the Na /Ca exchanger NCX3 due to a direct repression 
of its transcription. This study also demonstrated that overexpression of wild-type 
KChIP3 could result in downregulation of NCX3.
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Whilst this would apparently provide an explanation for the effects seen upon 
secretion and the modification of the [Ca2+]i seen in response to ATP stimulation, it 
is important to consider that the effect on NCX3 expression is thought to be due to 
the DREAM transcriptional regulator function. This would in turn suggest that the 
changes I observed may not be as a result of a change in NCX3 expression, as all 
four KChEPs are known to exhibit the DREAM transcriptional regulator function 
and therefore I would expect all four KChIPs to exhibit similar effects on secretion 
and Ca2+ signalling if they were as a result of the DREAM function. All four 
KChIPs have been demonstrated to bind to DRE sites and to be equally efficient in 
repressing the transcription from three separate promoters (Link et al., 2004). 
However, it would be of interest to examine whether the other KChIP isoforms do 
limit NCX3 expression in the same manner as KChIP3 has been shown to. This is 
something that is yet to be tested, and it may be that solely KChIP3 decreases NCX3 
expression at the plasma membrane, whether this is through a repression of 
transcription or possibly an effect on the trafficking of the exchanger to the plasma 
membrane.
Similarly, I cannot rule out effects via Kv4 channels which are regulated by all four 
KChIPs, and interactions with the presenilins. The presenilins are known to interact 
not only with KChIP3 but also KChIP4, but the functional experiments carried out 
here did not implicate a presenilin interaction in the KChIP3 effect on secretion or 
the Ca2+ response in PC 12 cells. Equally, functional experiments carried with the 
Kv4.2 channel did not implicate a channel interaction in the effects on secretion.
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The increase in filling of ER Ca stores is something that has been implied in the 
reported pro-apoptotic effect of KChIP3 in HeLa cells. Interestingly, my initial 
experiments found that KChIP3 but none of the other KChIP isoforms tested caused 
apoptosis in HeLa cells (data not shown), but this apoptotic effect does not appear to 
occur in COS-7 or PC 12 cell lines. The idea that Ca2+ signalling could be modified 
by KChIP3 overexpression leading to increased filling of ER Ca2+ stores is 
something that could be possible. Since the [Ca2+]i increase in response to ATP 
stimulation is due predominantly to Ca2+ entry rather than release from intracellular
a  I
stores, increased levels of ER Ca should not have any significant effect on peak
2 1 2'ECa response. However, the increase in ER Ca could conceivably prevent further
94-reuptake of Ca into the ER following ATP stimulation, thus increasing the time 
taken for the level of [Ca ]i to decline, accounting for the observed changes here.
Obviously whilst the functional data presented here demonstrates that KChIP3 has 
an effect on both secretion and Ca2+ response to ATP stimulation, the precise 
mechanism by which this occurs is something that is yet to be fully elucidated. The 
most likely explanations would appear to be either by an increase in ER Ca2+ store 
filling or by a decrease in the expression of the plasma membrane Na+/Ca2+ 
exchanger NCX3, though interactions with other proteins such as the presenilins or 
the Kv4 channels cannot be ruled out. Clearly more work is required to fully 
understand the processes by which KChIP3 is producing its effects, though the work
94 -
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carried out so far would suggest that this multi-talented protein may indeed carry out 
another specific functional role within the cell.
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CHAPTER 5:
General Discussion
A large part of this study concerned a comparative investigation into some of the 
known functions of the four KChIP proteins and their ability carry out multiple 
cellular roles. This work utilised GFP-variant fusion proteins expressed in both 
COS-7 and PC 12 cell lines, and imaged by confocal microscopy. The key findings 
demonstrated that whilst the KChIPs do indeed share some functional roles, such as 
the stimulation of traffic of the Kv4.2 channel to the plasma membrane, they also 
maintain unique functions specific to each particular KChIP, such as the ability to 
inhibit Kvl.4 traffic to the plasma membrane (KChIP2.3), to interact with 
presenilin-1 (KCMP3.1), and to enhance secretion through an effect on Ca 
signalling (KChIP3.1).
To date, sixteen different isoforms of the different KChIP sub-family members have 
been identified, with previous studies finding differences between isoforms of the 
same KChIP gene in terms of Kv channel modulation (Deschenes et al., 2002; 
Holmqvist et al., 2002; Van Hoorick et al., 2003; Patel et al., 2004). The variable 
effects of these different isoforms, together with the potential for the KChIPs to form 
homo- or hetero-oligomers (Osawa et al., 2001) raise the possibility that the KChIPs 
may be able to subtly modify channel expression and function. It would be 
interesting to discover the differing expression pattern for each particular splice 
variant, and elucidate whether particular KChIP isoforms are limited to particular 
neuronal cell types along with specific Kv channel isoforms to modulate their 
function as desired for that individual cell type. It is quite possible that cell-type 
specific expression of different KChIPs and different isoforms, in conjunction with
154
the differential intracellular targeting displayed by different KChIP isoforms, are 
important in terms of regulating specific channel isoforms in specific cell types.
The extent to which KChIP functions overlap remains unclear. However, the work 
carried out during the course of this investigation demonstrates that whilst the 
KChIPs do perform some similar roles within the cell, they also maintain distinct 
individual properties. Only KChIP2.3 for example was found to inhibit Kvl.4 
channel trafficking to the plasma membrane. However, it is KChIP3.1 that seems to 
possess the greatest variation in functional ability. In addition to an ability to 
stimulate the traffic of Kv4 channels to the plasma membrane, it has been reported 
to interact with the presenilins, act as a repressor of transcription through an 
interaction with DRE residues and possess a pro-apoptotic function. Furthermore, in 
this study I demonstrated a novel effect of KChIP3.1 on Ca2+ responses to purinergic 
receptor stimulation and on secretion in PC 12 cells. The effect upon secretion in 
response to ATP stimulation is likely to be a direct result of the elongation of the 
Ca signal, although the precise mechanism behind this prolonged signal remains to 
be determined. Previous investigations have described two potential answers to this 
question, with KChIP3 expression reported to result in an increased filling of the ER 
Ca2+ stores and a lower expression of the Na+/Ca2+ exchanger NCX3 due to a direct 
repression of its transcription. In the latter case, the lower expression of NCX3 was 
attributed to the DREAM function of KChIP3, although as all four KChIPs are 
reported to exhibit the DREAM transcriptional regulator function, it would be 
interesting to investigate whether or not the other KChIPs limit NCX3 expression in
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the same manner as KChIP3 has been shown to. If the expression of NCX3 is 
limited specifically by KChIP3, this would potentially provide an explanation for the 
functional data presented in this thesis. Furthermore, it would be of interest to 
investigate the shorter splice variant of KChIP3 (KChIP3.2) to discover whether or 
not this isoform shares the ability to modify the Ca2+ signal in a similar manner. 
Further work to determine the full range of target proteins for each of the KChIPs 
would also be of interest, potentially by completing a yeast two-hybrid screen for all 
four KChIPs, or by making GST-tagged versions of the proteins in order to perform 
a GST-pull-down assay with brain lysates, allowing subsequent identification of 
interacting proteins by mass spectroscopy. This could be followed up by functional 
studies in order to determine the significance of any potential interactions.
Clearly additional work is required in order to fully appreciate the multiple functions 
of this particular sub-family of the NCS proteins. It is becoming increasingly clear 
that differential expression of multiple isoforms of the KChIPs in neuronal cells may 
be important for the subtle regulation of a number of interacting partners, and that 
the KChIPs are much more than simply an accessory subunit of Kv4 channels. It 
would be of interest to discover the implications of the co-expression of multiple 
KChIP isoforms, based on the determination of the specific neuronal patterns of 
expression, and perform co-expression studies in model cell types. One example 
would be to investigate the co-expression of KChIP3.1 with isoforms of KChIPs 1,
2, and 4 with respect to the novel function revealed in this thesis and look for subtle 
modifications of secretion and Ca signalling.
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